,Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes,source,Enrichment_Term,score,significance_str,immune_related
0,prerank,KEGG_2021_Human__Ribosome,-0.6930564493693042,-2.918215715737111,0.0,0.0,0.0,51/89,14.84%,RPS9;RPL37;FAU;RPS7;RPS15A;RPLP1;RPS3A;RPS3;RPS15;RPS4Y2;RPL34;RPL37A;RPL28;RPS8;RPS23;RPS18;MRPL33;RPL26;RPL12;RPL39;RPS14;RPS25;RPL27A;RPL3;RPL23;RPS11;UBA52;RPL35A;RPS13;RPL31;RPL29;RPS24;RPL24;RPL35;RPLP0;RPL13;RPS21;RPS20;RPL30;RPL7A;RPS12;RPL8;RPS17;RPL13A;RPS29;RPL6;RPL7;RPL15;RPL9;RPL18;RPL11,KEGG_2021_Human,Ribosome,5.0,****,False
4,prerank,KEGG_2021_Human__Dopaminergic synapse,-0.630339813393453,-2.146215332132745,0.0,0.000739795572085952,0.001,11/31,12.02%,FOS;PPP2R5A;CALM1;GNAI2;PPP3CA;AKT1;CALM2;MAPK13;MAPK14;GNAS;CREB5,KEGG_2021_Human,Dopaminergic synapse,3.130888272404772,***,False
8,prerank,KEGG_2021_Human__Amphetamine addiction,-0.7275255833026077,-2.0357185334316386,0.0,0.004931970480573013,0.01,8/15,12.02%,FOS;CALM1;JUN;PPP3CA;CALM2;FOSB;GNAS;CREB5,KEGG_2021_Human,Amphetamine addiction,2.3069795314604535,**,False
10,prerank,KEGG_2021_Human__Coronavirus disease,-0.45297913360924036,-2.0006302442912465,0.0,0.004438773432515712,0.012,58/126,14.84%,RPS9;FOS;IL1B;RPL37;FAU;RPS7;RPS15A;RPLP1;RPS3A;RPS3;RPS15;RPS4Y2;RPL34;RPL37A;JUN;RPL28;RPS8;RPS23;RPS18;RPL26;RPL12;RPL39;RPS14;RPS25;RPL27A;RPL3;RPL23;RPS11;UBA52;RPL35A;RPS13;RPL31;RPL29;RPS24;RPL24;RPL35;RPLP0;RPL13;RPS21;RPS20;MAPK13;RPL30;MAPK14;RPL7A;C3;RPS12;RPL8;MAPK3;RPS17;RPL13A;RPS29;RPL6;RPL7;RPL15;NLRP3;RPL9;RPL18;RPL11,KEGG_2021_Human,Coronavirus disease,2.3527370220211288,**,True
18,prerank,KEGG_2021_Human__Estrogen signaling pathway,-0.5672206185840218,-1.9185424202380255,0.0,0.012724483839878373,0.04,19/31,26.00%,FOS;RARA;MMP9;CALM1;JUN;GNAI2;AKT1;CALM2;HSP90AB1;GNAS;MAPK3;CREB5;SOS2;GRB2;PIK3CB;KRAS;NCOA3;RAF1;HSP90AA1,KEGG_2021_Human,Estrogen signaling pathway,1.8953598254972233,*,False
19,prerank,KEGG_2021_Human__Vascular smooth muscle contraction,-0.6213575445108249,-1.8718388769816916,0.00510204081632653,0.015535707013804991,0.059,10/21,12.75%,MYL6;CALM1;MYH9;CALM2;ROCK1;GNAS;MAPK3;CALCRL;PPP1R12A;ARHGEF1,KEGG_2021_Human,Vascular smooth muscle contraction,1.8086689776708529,*,False
20,prerank,KEGG_2021_Human__Oocyte meiosis,-0.5568166150889851,-1.8404223577106484,0.0029239766081871343,0.019234684874234752,0.079,16/29,30.69%,PPP2R5A;CALM1;PPP3CA;CALM2;MAPK13;MAPK14;MAPK3;PPP3R1;RBX1;YWHAZ;PPP1CA;CDC26;PPP2R5C;SLK;YWHAB;YWHAQ,KEGG_2021_Human,Oocyte meiosis,1.7159149244339542,*,False
22,prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.505822793199233,-1.8187345548441927,0.0,0.022008918269557073,0.098,27/45,28.20%,FOS;JUN;GSTP1;MGST1;GNAI2;PTGS2;AKT1;HSP90AB1;VEGFA;GNAS;BCL6;MAPK3;CREB5;EIF4EBP1;STAT5B;NOTCH2;SOS2;ADRB2;GRB2;PIK3CB;KRAS;KLF4;RAF1;HSP90AA1;CCND3;PTGES3;ATF4,KEGG_2021_Human,Chemical carcinogenesis,1.6574013023402039,*,False
24,prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,-0.43618862709536715,-1.7932420978030061,0.0,0.027125837643151574,0.132,31/69,21.92%,ARPC1B;TMSB4Y;ITGB2;ARPC2;RAC1;ACTB;WASF2;SSH2;MYH9;ROCK1;MAPK3;ITGA4;PPP1R12A;ARHGEF1;ITGAL;ACTR2;FN1;PIP4K2A;IQGAP1;ACTR3;ITGB7;PXN;ACTN1;SOS2;ARHGEF6;EZR;MSN;NCKAP1L;PIK3CB;ARPC3;KRAS,KEGG_2021_Human,Regulation of actin cytoskeleton,1.5666168419662097,*,False
26,prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,-0.6197723124387046,-1.7854633327121516,0.005376344086021506,0.0261887632518427,0.143,12/19,27.41%,GNAI2;AKT1;MAPK13;HSP90AB1;MAPK14;MAPK3;STK10;PIK3CB;KRAS;RAF1;HSP90AA1;CDC26,KEGG_2021_Human,Progesterone-mediated oocyte maturation,1.5818850103789843,*,False
27,prerank,KEGG_2021_Human__Oxytocin signaling pathway,-0.49967619801466734,-1.7665059733201753,0.0,0.028650264882601414,0.164,14/39,11.07%,FOS;RGS2;MYL6;CALM1;JUN;GNAI2;PTGS2;PPP3CA;ACTB;CALM2;ROCK1;GNAS;MAPK3;PPP1R12A,KEGG_2021_Human,Oxytocin signaling pathway,1.5428713584602785,*,False
29,prerank,KEGG_2021_Human__VEGF signaling pathway,-0.5735832501796791,-1.7484733167338489,0.005390835579514825,0.03304420221983919,0.195,12/23,21.92%,PTGS2;PPP3CA;RAC1;AKT1;MAPK13;VEGFA;MAPK14;MAPK3;PXN;PPP3R1;PIK3CB;KRAS,KEGG_2021_Human,VEGF signaling pathway,1.480904728759627,*,False
32,prerank,KEGG_2021_Human__Relaxin signaling pathway,-0.4956035425187999,-1.69275551055758,0.0,0.049054137164468506,0.287,16/34,21.92%,FOS;MMP9;JUN;GNAI2;AKT1;MAPK13;VEGFA;MAPK14;GNAS;MAPK3;CREB5;GNG10;SOS2;GRB2;PIK3CB;KRAS,KEGG_2021_Human,Relaxin signaling pathway,1.3093243588868961,*,False
34,prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.43087240303389274,-1.659898221586557,0.0,0.0620371429734934,0.355,22/53,23.30%,FLNA;RALBP1;MARCKS;MID1IP1;WASF2;SSH2;MYH9;SPTBN1;ROCK1;CLIP1;TUBA4A;ARAP3;NOTCH2;SPTAN1;PXN;ARF6;EZR;PCM1;NCK1;ARFGEF1;FGD4;AKAP13,MSigDB_Hallmark_2020,Mitotic Spindle,1.2073482111714147,ns,False
39,prerank,KEGG_2021_Human__Tight junction,-0.43488531689618964,-1.6126388553515925,0.0035971223021582736,0.08976186274642885,0.492,19/48,21.80%,ARPC1B;MYL6;JUN;ARPC2;RAC1;ACTB;MYH9;ROCK1;ARHGEF18;TUBA4A;WAS;ACTR2;RAP1A;ACTR3;TUBA1A;ACTN1;EZR;MSN;ARPC3,KEGG_2021_Human,Tight junction,1.0469081434753786,ns,False
42,prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.4221966159459208,-1.5813574628128622,0.006289308176100629,0.10921232132918868,0.572,17/51,9.23%,FOS;IL1B;KLF2;DUSP1;MMP9;CALM1;JUN;GSTP1;MGST1;RAC1;ACTB;AKT1;CALM2;MAPK13;HSP90AB1;VEGFA;MAPK14,KEGG_2021_Human,Fluid shear stress and atherosclerosis,0.961728361783201,ns,False
45,prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,-0.4521800010972112,-1.5585000399382096,0.020114942528735632,0.12123943904890955,0.621,13/34,18.39%,RGS2;CALM1;GNAI2;PPP3CA;AKT1;CALM2;ROCK1;MAPK3;PPP1R12A;CREB5;PIK3CG;PPP3R1;ADRB2,KEGG_2021_Human,cGMP-PKG signaling pathway,0.9163560816951015,ns,False
46,prerank,KEGG_2021_Human__Gap junction,-0.5332641857030681,-1.5499012235284153,0.022222222222222223,0.12149087283811522,0.638,10/18,21.92%,GNAI2;TUBB4B;GNAS;MAPK3;TUBB2A;TUBA4A;TUBA1A;SOS2;GRB2;KRAS,KEGG_2021_Human,Gap junction,0.9154563477852902,ns,False
48,prerank,KEGG_2021_Human__GnRH signaling pathway,-0.524246507768511,-1.538624567506879,0.028350515463917526,0.12576524725461183,0.664,13/22,28.20%,CALM1;JUN;CALM2;MAPK13;MAPK14;GNAS;MAPK3;MAP3K3;SOS2;GRB2;KRAS;RAF1;ATF4,KEGG_2021_Human,GnRH signaling pathway,0.9004393510264983,ns,False
49,prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.45480495285642947,-1.5364306136565467,0.01483679525222552,0.12110453515047034,0.666,14/34,11.65%,S100A9;S100A8;FOS;IL1B;JUND;MMP9;JUN;PTGS2;MAPK13;HSP90AB1;MAPK14;FOSB;MAPK3;IL17RA,KEGG_2021_Human,IL-17 signaling pathway,0.9168395929928308,ns,True
50,prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,-0.5602845884438635,-1.535758922241253,0.03217821782178218,0.11583084957231476,0.67,8/16,22.41%,CALM1;CALM2;PIP4K2A;PTEN;DGKH;MTMR3;PIK3CB;IMPA1,KEGG_2021_Human,Phosphatidylinositol signaling system,0.9361757582706787,ns,False
51,prerank,KEGG_2021_Human__Cholinergic synapse,-0.49786758794388397,-1.524704489126505,0.025839793281653745,0.1210574572504285,0.698,10/21,21.92%,FOS;GNAI2;AKT1;MAPK3;CREB5;PIK3CG;GNG10;KCNJ2;PIK3CB;KRAS,KEGG_2021_Human,Cholinergic synapse,0.9170084524596912,ns,False
53,prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.46040119213613984,-1.509245056437485,0.04229607250755287,0.1279524689459964,0.728,12/28,21.80%,ARPC1B;ARPC2;RAC1;ACTB;WASF2;ILK;ACTR2;FN1;ACTR3;PXN;PIK3CB;ARPC3,KEGG_2021_Human,Bacterial invasion of epithelial cells,0.8929513296339483,ns,False
54,prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.41145435508164174,-1.5051561228599855,0.0364741641337386,0.12644339319569062,0.737,23/46,33.05%,GNAI2;PTGS2;MAPK13;ND4;MAPK14;MAPK3;ND1;NDUFA1;NDUFA3;GNG10;NDUFA5;NDUFS7;NDUFA13;NDUFB7;NDUFB8;ND5;NDUFS5;NDUFAB1;NDUFA8;GNB2;DAGLB;NDUFB10;NDUFA4,KEGG_2021_Human,Retrograde endocannabinoid signaling,0.8981038580840308,ns,False
57,prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.47343729826714176,-1.4765183778681001,0.050505050505050504,0.1481958490002579,0.79,10/23,17.04%,SRI;DUSP1;ADD3;CDKN1B;GCNT1;MAPK14;INSIG1;PTEN;NOTCH2;CITED2,MSigDB_Hallmark_2020,UV Response Dn,0.8291639608744366,ns,False
59,prerank,KEGG_2021_Human__Yersinia infection,-0.3722652668521734,-1.472576794696789,0.014336917562724014,0.14665024532811524,0.799,26/64,22.53%,FOS;IL1B;ARPC1B;JUN;ARPC2;RAC1;ACTB;AKT1;WASF2;MAPK13;MAPK14;ROCK1;MAPK3;ITGA4;WAS;ARHGEF1;ACTR2;FN1;NLRP3;ACTR3;PXN;SKAP2;ARF6;PIK3CB;ARPC3;MYD88,KEGG_2021_Human,Yersinia infection,0.8337172061607043,ns,True
61,prerank,KEGG_2021_Human__ErbB signaling pathway,-0.4929859186903096,-1.4585958622512307,0.04784688995215311,0.15612426554613903,0.822,12/20,25.90%,JUN;CDKN1B;AKT1;MAPK3;EIF4EBP1;STAT5B;SOS2;GRB2;PIK3CB;KRAS;NCK1;RAF1,KEGG_2021_Human,ErbB signaling pathway,0.8065295916603016,ns,False
62,prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,-0.42202875445253735,-1.4427274358907334,0.053763440860215055,0.16629547609674936,0.854,12/31,18.39%,PPP2R5A;CALM1;GNAI2;AKT1;CALM2;MAPK13;MAPK14;GNAS;MAPK3;CREB5;PIK3CG;ADRB2,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,0.77911956516979,ns,False
66,prerank,KEGG_2021_Human__Alcoholism,-0.42266714213249523,-1.4058541806139904,0.04404145077720207,0.2047958225071042,0.907,14/29,28.20%,CALM1;GNAI2;CALM2;FOSB;GNAS;MAPK3;CREB5;GNG10;SOS2;GRB2;KRAS;PPP1CA;RAF1;ATF4,KEGG_2021_Human,Alcoholism,0.6886789064882805,ns,False
68,prerank,KEGG_2021_Human__Wnt signaling pathway,-0.4507563979571885,-1.3944759185871398,0.09230769230769231,0.21237064889347396,0.917,12/22,27.04%,JUN;PPP3CA;RAC1;FRAT2;SENP2;PPP3R1;SMAD4;RBX1;TBL1Y;TBL1XR1;CTBP1;CCND3,KEGG_2021_Human,Wnt signaling pathway,0.672905505972985,ns,False
69,prerank,KEGG_2021_Human__cAMP signaling pathway,-0.38995028492955497,-1.3939788326367921,0.05013927576601671,0.20637910023868752,0.917,15/41,16.09%,FOS;CALM1;JUN;GNAI2;RAC1;AKT1;CALM2;ROCK1;GNAS;MAPK3;PPP1R12A;CREB5;RAP1A;ARAP3;ORAI1,KEGG_2021_Human,cAMP signaling pathway,0.6853342852937909,ns,False
70,prerank,KEGG_2021_Human__FoxO signaling pathway,-0.3801591444373793,-1.3920217622445474,0.045317220543806644,0.20219537729574175,0.918,18/46,21.92%,GADD45A;KLF2;CDKN2D;CDKN1B;S1PR4;CCNG2;AKT1;MAPK13;MAPK14;BCL6;MAPK3;PTEN;GABARAPL2;SOS2;GRB2;SMAD4;PIK3CB;KRAS,KEGG_2021_Human,FoxO signaling pathway,0.69422877771584,ns,False
73,prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.42629540187084636,-1.3887375524061127,0.05333333333333334,0.2008208707498775,0.923,14/29,21.92%,FOS;JUNB;GNAI2;AKT1;MAPK13;MAPK14;GNAS;MAPK3;CREB5;STAT5B;SOS2;GRB2;PIK3CB;KRAS,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",0.6971911541739907,ns,False
74,prerank,KEGG_2021_Human__Serotonergic synapse,-0.4899720555339109,-1.3828261088665537,0.09352517985611511,0.20252991720517768,0.934,10/16,30.63%,DUSP1;GNAI2;PTGS2;GNAS;MAPK3;GNG10;KRAS;RAF1;ALOX5;GNB2,KEGG_2021_Human,Serotonergic synapse,0.693510814832335,ns,False
77,prerank,KEGG_2021_Human__Glucagon signaling pathway,-0.44309168346728595,-1.3709401134526407,0.08055555555555556,0.21268065846653855,0.945,7/24,12.02%,CALM1;PPP3CA;PYGL;AKT1;CALM2;GNAS;CREB5,KEGG_2021_Human,Glucagon signaling pathway,0.6722720037653185,ns,False
78,prerank,KEGG_2021_Human__Rap1 signaling pathway,-0.3559467947564314,-1.3654332522555248,0.05466237942122187,0.21425301762689267,0.948,19/57,14.35%,ITGB2;CALM1;RASGRP2;GNAI2;RAC1;ACTB;AKT1;RGS14;TLN1;CALM2;MAPK13;VEGFA;MAPK14;GNAS;MAPK3;CSF1R;ITGAL;RAP1A;ARAP3,KEGG_2021_Human,Rap1 signaling pathway,0.6690730525810592,ns,False
79,prerank,KEGG_2021_Human__Breast cancer,-0.4106268276463346,-1.3519780911610921,0.07202216066481995,0.22485786496428692,0.957,17/31,25.90%,FOS;GADD45A;JUN;AKT1;FRAT2;MAPK3;E2F2;NOTCH1;PTEN;NOTCH2;SOS2;GRB2;PIK3CB;KRAS;NCOA3;HES1;RAF1,KEGG_2021_Human,Breast cancer,0.6480919172983831,ns,False
81,prerank,KEGG_2021_Human__Long-term potentiation,-0.46008137169389485,-1.3449810970146872,0.10406091370558376,0.22921981751947365,0.961,10/18,28.20%,CALM1;PPP3CA;CALM2;MAPK3;RAP1A;PPP3R1;KRAS;PPP1CA;RAF1;ATF4,KEGG_2021_Human,Long-term potentiation,0.6397478375454322,ns,False
82,prerank,KEGG_2021_Human__Cushing syndrome,-0.45085217903808483,-1.3384779506426865,0.10204081632653061,0.23168879788353378,0.961,8/20,16.09%,CDKN1B;GNAI2;GNAS;MAPK3;E2F2;CREB5;RAP1A;ORAI1,KEGG_2021_Human,Cushing syndrome,0.6350949637714246,ns,False
83,prerank,KEGG_2021_Human__Cell cycle,-0.4378767869017063,-1.3381728239793909,0.14244186046511628,0.22637744505830132,0.962,12/23,30.69%,GADD45A;CDKN2D;CDKN1B;E2F2;SMAD4;RBX1;YWHAZ;CCND3;RAD21;CDC26;YWHAB;YWHAQ,KEGG_2021_Human,Cell cycle,0.6451668459231922,ns,False
84,prerank,KEGG_2021_Human__Choline metabolism in cancer,-0.4050001373606352,-1.3339084505411734,0.08839779005524862,0.22695484648041717,0.962,15/29,21.92%,FOS;JUN;RAC1;GPCPD1;AKT1;WASF2;MAPK3;WAS;EIF4EBP1;DGKH;SOS2;GRB2;SLC44A2;PIK3CB;KRAS,KEGG_2021_Human,Choline metabolism in cancer,0.6440605387319789,ns,False
86,prerank,KEGG_2021_Human__Glioma,-0.4268393228797393,-1.3217221592304107,0.11330049261083744,0.23754483536074164,0.97,11/24,21.92%,GADD45A;CALM1;AKT1;CALM2;MAPK3;E2F2;PTEN;SOS2;GRB2;PIK3CB;KRAS,KEGG_2021_Human,Glioma,0.6242544074620514,ns,False
87,prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,-0.47576685104508265,-1.3192653690758178,0.1553398058252427,0.23580553746535018,0.972,6/17,9.56%,IL1B;CALM1;CALM2;MAPK13;MAPK14;GNAS,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,0.6274460005029829,ns,True
90,prerank,KEGG_2021_Human__Platelet activation,-0.368708392467263,-1.3076652620159277,0.09393939393939393,0.24665456914774808,0.977,17/39,16.09%,RASGRP2;GNAI2;ACTB;AKT1;TLN1;MAPK13;MAPK14;ROCK1;GNAS;MAPK3;PPP1R12A;FERMT3;ARHGEF1;SNAP23;RAP1A;PIK3CG;ORAI1,KEGG_2021_Human,Platelet activation,0.607910835047677,ns,False
92,prerank,KEGG_2021_Human__Calcium signaling pathway,-0.4265975773162518,-1.2911402824267113,0.1509433962264151,0.2656688098868663,0.983,8/20,18.39%,CALM1;PPP3CA;CALM2;VEGFA;GNAS;ORAI1;PPP3R1;ADRB2,KEGG_2021_Human,Calcium signaling pathway,0.5756594297415486,ns,True
97,prerank,KEGG_2021_Human__Hepatocellular carcinoma,-0.3621728304236376,-1.2797127745495662,0.09142857142857143,0.27742333953223197,0.986,14/40,21.92%,GADD45A;GSTP1;MGST1;ACTB;AKT1;FRAT2;MAPK3;E2F2;PTEN;SOS2;GRB2;SMAD4;PIK3CB;KRAS,KEGG_2021_Human,Hepatocellular carcinoma,0.5568570046770535,ns,False
98,prerank,KEGG_2021_Human__Focal adhesion,-0.3339878194813061,-1.2751297914616748,0.10299003322259136,0.2786038643813053,0.986,21/50,18.85%,FLNA;JUN;RAC1;ACTB;AKT1;ZYX;TLN1;VEGFA;ROCK1;MAPK3;ILK;ITGA4;PPP1R12A;FN1;RAP1A;PTEN;ITGB7;PXN;ACTN1;SOS2;GRB2,KEGG_2021_Human,Focal adhesion,0.5550128639786831,ns,False
99,prerank,KEGG_2021_Human__Cellular senescence,-0.34620857776876557,-1.2688554916586403,0.12461059190031153,0.2820162370422656,0.989,14/50,14.38%,GADD45A;ZFP36L2;CALM1;HIPK1;PPP3CA;AKT1;CALM2;MAPK13;MAPK14;MAPK3;E2F2;ZFP36L1;EIF4EBP1;PTEN,KEGG_2021_Human,Cellular senescence,0.5497258865215772,ns,False
100,prerank,KEGG_2021_Human__Central carbon metabolism in cancer,-0.40652092384596605,-1.2650507673077278,0.14175257731958762,0.2816054491948403,0.99,13/24,35.74%,SLC16A3;AKT1;MAPK3;PTEN;PIK3CB;KRAS;G6PD;RAF1;HK3;IDH1;PIK3CA;AKT2;PGAM4,KEGG_2021_Human,Central carbon metabolism in cancer,0.5503589456508314,ns,False
102,prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,-0.30200362475899156,-1.2415704741811795,0.10606060606060606,0.3119865886600877,0.994,22/79,13.58%,FOS;IL1B;ARPC1B;RPS3;JUN;ARPC2;TUBB4B;GAPDH;MYO1F;RAC1;ACTB;WASF2;MYH9;MAPK13;MAPK14;ROCK1;MAPK3;TUBB2A;TUBA4A;ARHGEF1;ACTR2;NLRP3,KEGG_2021_Human,Pathogenic Escherichia coli infection,0.505864074558817,ns,True
104,prerank,MSigDB_Hallmark_2020__Glycolysis,-0.3270892134007875,-1.2142273643989279,0.13953488372093023,0.355101874601257,0.996,13/47,17.04%,PGK1;ALDOA;TALDO1;SLC16A3;PYGL;KIF2A;VEGFA;SAP30;MXI1;TXN;ENO1;UGP2;CITED2,MSigDB_Hallmark_2020,Glycolysis,0.449647035029185,ns,False
105,prerank,KEGG_2021_Human__Gastric cancer,-0.3720562526513195,-1.2090771596732828,0.17135549872122763,0.3577196127794072,0.997,11/28,21.92%,GADD45A;CDKN1B;AKT1;FRAT2;MAPK3;E2F2;SOS2;GRB2;SMAD4;PIK3CB;KRAS,KEGG_2021_Human,Gastric cancer,0.4464572480300478,ns,False
106,prerank,KEGG_2021_Human__Adherens junction,-0.4072960117783532,-1.2052631544732388,0.22911051212938005,0.357726055121109,0.997,8/20,20.57%,RAC1;ACTB;WASF2;MAPK3;WAS;IQGAP1;ACTN1;SMAD4,KEGG_2021_Human,Adherens junction,0.44644942668573834,ns,False
107,prerank,KEGG_2021_Human__MicroRNAs in cancer,-0.3269574965753222,-1.2019285990368744,0.15692307692307692,0.3575130601695371,0.997,19/45,21.92%,VIM;MMP9;MARCKS;CDKN1B;PTGS2;VEGFA;ROCK1;MAPK3;E2F2;NOTCH1;PTEN;NOTCH2;PIM1;SOS2;GRB2;EZR;PIK3CB;DDIT4;KRAS,KEGG_2021_Human,MicroRNAs in cancer,0.44670808853154015,ns,False
109,prerank,KEGG_2021_Human__MAPK signaling pathway,-0.29693359390080065,-1.1830395368597237,0.17647058823529413,0.38767978143020565,0.998,20/76,14.19%,FOS;GADD45A;IL1B;JUND;FLNA;DUSP1;JUN;RASGRP2;PPP3CA;RAC1;AKT1;DUSP7;MAPK13;VEGFA;MAPK14;MAPK3;CSF1R;MKNK2;MAP3K3;RAP1A,KEGG_2021_Human,MAPK signaling pathway,0.41152684805717354,ns,False
112,prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.3587145264656635,-1.1790506910750314,0.22096317280453256,0.3884719391564197,0.998,5/28,5.18%,CDKN2D;GSR;MGST1;JUNB;GPX4,MSigDB_Hallmark_2020,Reactive Oxygen Species Pathway,0.4106403465146994,ns,False
115,prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,-0.3210883756057422,-1.1724338798980232,0.19692307692307692,0.3936231598284694,0.999,13/48,14.10%,PADI4;CAMP;SELPLG;ITGB2;RAC1;ACTB;AKT1;MAPK13;MAPK14;C3;MAPK3;ITGAL;CR1L,KEGG_2021_Human,Neutrophil extracellular trap formation,0.40491935665888534,ns,True
116,prerank,KEGG_2021_Human__Th17 cell differentiation,-0.3389720179083846,-1.1715092634735336,0.21447721179624665,0.38857124669011106,0.999,9/34,9.84%,FOS;IL1B;RARA;JUN;PPP3CA;MAPK13;HSP90AB1;MAPK14;MAPK3,KEGG_2021_Human,Th17 cell differentiation,0.4105293392633292,ns,False
117,prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.29545490345023,-1.1672305919290227,0.1824561403508772,0.3904114395333594,0.999,18/61,19.34%,GADD45A;ALDOA;TKT;TALDO1;GPX4;CCNG2;TOB1;C3;BCL6;RTN3;ESYT1;ALDH2;ARL4A;REEP5;ECH1;RIOK3;ETFB;NDUFA5,MSigDB_Hallmark_2020,Adipogenesis,0.4084774654586585,ns,False
119,prerank,KEGG_2021_Human__Prostate cancer,-0.35360316208828946,-1.1577293361422478,0.25132275132275134,0.4016350160854633,0.999,15/28,26.00%,MMP9;GSTP1;CDKN1B;AKT1;HSP90AB1;MAPK3;E2F2;CREB5;PTEN;SOS2;GRB2;PIK3CB;KRAS;RAF1;HSP90AA1,KEGG_2021_Human,Prostate cancer,0.3961684307490924,ns,True
121,prerank,KEGG_2021_Human__Pertussis,-0.3298418205660305,-1.1553519500030818,0.2288135593220339,0.3993683309637771,0.999,11/37,9.84%,FOS;IL1B;ITGB2;CALM1;JUN;GNAI2;CALM2;MAPK13;MAPK14;C3;MAPK3,KEGG_2021_Human,Pertussis,0.3986263767036314,ns,False
122,prerank,KEGG_2021_Human__RNA degradation,-0.3827553571994531,-1.153099646081021,0.25761772853185594,0.39722249346357,1.0,5/19,14.29%,BTG2;TOB1;BTG1;CNOT6L;ENO1,KEGG_2021_Human,RNA degradation,0.4009661667463587,ns,False
123,prerank,KEGG_2021_Human__Glutathione metabolism,-0.41028638048932276,-1.152636812156087,0.2764423076923077,0.39150451386262924,1.0,5/15,5.18%,PGD;GSR;GSTP1;MGST1;GPX4,KEGG_2021_Human,Glutathione metabolism,0.40726322636636736,ns,False
124,prerank,KEGG_2021_Human__HIF-1 signaling pathway,-0.3209796595204856,-1.1463163035827464,0.2125748502994012,0.39673849414271944,1.0,10/43,14.29%,PGK1;ALDOA;CDKN1B;GAPDH;AKT1;VEGFA;MAPK3;MKNK2;EIF4EBP1;ENO1,KEGG_2021_Human,HIF-1 signaling pathway,0.4014956594131497,ns,False
125,prerank,KEGG_2021_Human__Bladder cancer,-0.4036740096474332,-1.1336478455747698,0.2932692307692308,0.41624313326657597,1.0,8/15,28.54%,MMP9;VEGFA;MAPK3;E2F2;DAPK3;KRAS;RAF1;DAPK1,KEGG_2021_Human,Bladder cancer,0.3806529179517692,ns,False
128,prerank,KEGG_2021_Human__Leukocyte transendothelial migration,-0.31039861101028027,-1.1217267149687056,0.24012158054711247,0.43340811500417303,1.0,17/41,20.88%,ITGB2;MMP9;GNAI2;RAC1;ACTB;MAPK13;MAPK14;ROCK1;ITGA4;ITGAL;RAP1A;PXN;ACTN1;RASSF5;EZR;MSN;PIK3CB,KEGG_2021_Human,Leukocyte transendothelial migration,0.3631029613398308,ns,False
129,prerank,KEGG_2021_Human__Leishmaniasis,-0.31566890274518555,-1.116673712179787,0.2542857142857143,0.4371418910281021,1.0,11/40,10.39%,FOS;IL1B;ITGB2;JUN;PTGS2;MAPK13;EEF1A1;MAPK14;C3;MAPK3;ITGA4,KEGG_2021_Human,Leishmaniasis,0.35937757335339404,ns,False
131,prerank,KEGG_2021_Human__Sphingolipid signaling pathway,-0.31209017040339165,-1.1127547807607634,0.2727272727272727,0.4380460134480702,1.0,9/42,9.84%,PPP2R5A;GNAI2;S1PR4;RAC1;AKT1;MAPK13;MAPK14;ROCK1;MAPK3,KEGG_2021_Human,Sphingolipid signaling pathway,0.3584802677219255,ns,False
132,prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,-0.3768629071447268,-1.106363206426729,0.3002481389578164,0.4458501314438005,1.0,5/18,14.29%,PGK1;ALDOA;GAPDH;ALDH2;ENO1,KEGG_2021_Human,Glycolysis / Gluconeogenesis,0.3508111009850901,ns,False
133,prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",-0.33953072054546996,-1.1048506155928846,0.3013698630136986,0.4424611631564352,1.0,7/28,12.75%,FOS;JUND;GNAI2;GNAS;MAPK3;CREB5;ARHGEF1,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",0.35412484330980243,ns,False
135,prerank,KEGG_2021_Human__Endometrial cancer,-0.35537113991428837,-1.0961849581206833,0.3193069306930693,0.4540677667656566,1.0,9/23,21.92%,GADD45A;AKT1;MAPK3;ILK;PTEN;SOS2;GRB2;PIK3CB;KRAS,KEGG_2021_Human,Endometrial cancer,0.3428793265788086,ns,False
136,prerank,KEGG_2021_Human__Chagas disease,-0.3078306169102405,-1.085853888292424,0.30952380952380953,0.46942084036553894,1.0,10/40,9.84%,FOS;IL1B;JUN;GNAI2;AKT1;MAPK13;MAPK14;C3;GNAS;MAPK3,KEGG_2021_Human,Chagas disease,0.32843763341053883,ns,False
137,prerank,KEGG_2021_Human__Axon guidance,-0.31694187374467725,-1.0797489467445587,0.3236842105263158,0.475800028896376,1.0,12/31,22.56%,GNAI2;PPP3CA;RAC1;SSH2;ROCK1;MAPK3;ILK;FES;PPP3R1;PIK3CB;KRAS;NCK1,KEGG_2021_Human,Axon guidance,0.32257553592309834,ns,False
138,prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,-0.36061645506705475,-1.0754519231836923,0.36103896103896105,0.479067619112957,1.0,5/18,13.00%,TSPO;S1PR4;C3;CALCRL;UTS2,KEGG_2021_Human,Neuroactive ligand-receptor interaction,0.3196031827544935,ns,False
139,prerank,KEGG_2021_Human__Notch signaling pathway,-0.3678281069497483,-1.0724235934487056,0.36061381074168797,0.47891406154556193,1.0,6/18,15.36%,CIR1;APH1B;PSENEN;NUMB;NOTCH1;NOTCH2,KEGG_2021_Human,Notch signaling pathway,0.3197424113140615,ns,False
143,prerank,KEGG_2021_Human__Apelin signaling pathway,-0.3026489982376757,-1.0465979394729883,0.38375350140056025,0.5288759608233413,1.0,11/36,21.92%,KLF2;CALM1;GNAI2;AKT1;CALM2;MAPK3;PIK3CG;GNG10;GABARAPL2;SMAD4;KRAS,KEGG_2021_Human,Apelin signaling pathway,0.2766461726653359,ns,False
144,prerank,MSigDB_Hallmark_2020__Apical Junction,-0.2851240606079179,-1.0449686105932714,0.3539325842696629,0.5255238727526936,1.0,18/41,20.88%,MMP9;PTPRC;ARPC2;GNAI2;ACTB;ZYX;MYH9;MAPK13;MAPK14;CNN2;INSIG1;PTEN;ACTN1;SKAP2;ARHGEF6;MSN;MAP4K2;PIK3CB,MSigDB_Hallmark_2020,Apical Junction,0.2794075506742315,ns,False
147,prerank,MSigDB_Hallmark_2020__Coagulation,-0.3034719875615629,-1.0328109002928711,0.37317784256559766,0.5473728468746726,1.0,10/36,14.22%,MMP8;ANXA1;MMP9;CFH;RAC1;LTA4H;C3;F12;FN1;CTSE,MSigDB_Hallmark_2020,Coagulation,0.26171675012096474,ns,False
149,prerank,KEGG_2021_Human__Pathways in cancer,-0.2294236114524905,-1.0306791839997511,0.3738738738738739,0.5453885331428588,1.0,28/134,12.97%,FOS;GADD45A;RARA;MMP9;RALBP1;CALM1;JUN;GSTP1;RASGRP2;MGST1;CDKN1B;GNAI2;PTGS2;RAC1;AKT1;CSF3R;CALM2;FRAT2;HSP90AB1;VEGFA;ROCK1;GNAS;MAPK3;E2F2;CSF1R;ARHGEF1;NOTCH1;FN1,KEGG_2021_Human,Pathways in cancer,0.26329399739023285,ns,False
151,prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.3143670936827728,-1.026068603072749,0.41076487252124644,0.5489653042663807,1.0,15/28,34.43%,AKT1;MAPK13;MAPK14;MAPK3;ID3;GRB2;SMAD4;PIK3CB;KRAS;KLF4;RAF1;BMPR2;PIK3CA;STAT3;AKT2,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,0.26045510298490976,ns,False
152,prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.257975673373788,-1.0233027204222775,0.38596491228070173,0.54766792203163,1.0,28/63,30.59%,NUDT4;BTG2;NFE2;CIR1;ARL2BP;C3;E2F2;MXI1;ADIPOR1;CTSE;TENT5C;FBXO9;KLF3;ADD1;RIOK3;TNRC6B;PICALM;UCP2;AGPAT4;NCOA4;HEBP1;BSG;CCND3;RBM38;CAT;CAST;KDM7A;MGST3,MSigDB_Hallmark_2020,heme Metabolism,0.2614826957932103,ns,False
153,prerank,KEGG_2021_Human__Diabetic cardiomyopathy,-0.23876599010184796,-1.0126876423890645,0.44176706827309237,0.5645361966793458,1.0,44/99,37.06%,MMP9;GSR;GAPDH;RAC1;AKT1;CYTB;MAPK13;ND4;MAPK14;ND1;NDUFA1;NDUFA3;PTEN;ATP5PB;MPC1;NDUFA5;COX1;NDUFS7;PIK3CB;ATP5F1D;NDUFA13;PPP1CA;NDUFB7;NDUFB8;ND5;G6PD;NDUFS5;COX7A2L;NDUFAB1;NDUFA8;COX2;PIK3CA;NCF2;NDUFB10;ATP5F1C;ATP5F1E;NDUFA4;AKT2;CYBB;NDUFA2;ATP2A3;NDUFA6;ATP5MC2;SDHD,KEGG_2021_Human,Diabetic cardiomyopathy,0.24830820694693573,ns,False
155,prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.28921478314063526,-1.0047405839895212,0.4489795918367347,0.5758105246734538,1.0,9/37,13.03%,GADD45A;VIM;FLNA;JUN;COLGALT1;VEGFA;SAT1;FN1;RHOB,MSigDB_Hallmark_2020,Epithelial Mesenchymal Transition,0.23972040134430023,ns,False
157,prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.2570122285653124,-0.9924347124389598,0.47157190635451507,0.5978957356877513,1.0,22/58,21.92%,FLNA;MMP9;DDX5;RAC1;ACTB;AKT1;MAPK13;VEGFA;MAPK14;ROCK1;MAPK3;PPP1R12A;ARHGEF1;FN1;IQGAP1;PXN;SOS2;GRB2;EZR;MSN;PIK3CB;KRAS,KEGG_2021_Human,Proteoglycans in cancer,0.2233745440441132,ns,False
158,prerank,KEGG_2021_Human__Melanoma,-0.33241399180504116,-0.9881572974799925,0.46296296296296297,0.600435493259596,1.0,7/19,21.92%,GADD45A;AKT1;MAPK3;E2F2;PTEN;PIK3CB;KRAS,KEGG_2021_Human,Melanoma,0.22153364342546525,ns,False
161,prerank,KEGG_2021_Human__Chronic myeloid leukemia,-0.2922421142412595,-0.967222193319699,0.5249343832020997,0.644275920545924,1.0,11/31,21.92%,GADD45A;CDKN1B;AKT1;MAPK3;E2F2;STAT5B;SOS2;GRB2;SMAD4;PIK3CB;KRAS,KEGG_2021_Human,Chronic myeloid leukemia,0.19092809986497303,ns,False
164,prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,-0.270708297701139,-0.9507845360466309,0.5164179104477612,0.6776527440307321,1.0,11/38,15.24%,ARPC1B;MARCKS;PTPRC;ARPC2;RAC1;AKT1;WASF2;MAPK3;WAS;ACTR2;ACTR3,KEGG_2021_Human,Fc gamma R-mediated phagocytosis,0.16899279873692183,ns,False
165,prerank,KEGG_2021_Human__Thermogenesis,-0.224301193309379,-0.94522471636714,0.5843621399176955,0.6835879221431489,1.0,37/95,33.05%,ACTB;CYTB;MAPK13;ND4;MAPK14;GNAS;ND1;NDUFA1;CREB5;NDUFA3;ATP5PB;ATP5MG;SOS2;ATP5ME;GRB2;NDUFA5;COX1;NDUFS7;ATP5F1D;KRAS;NDUFA13;NDUFB7;NDUFB8;ND5;NDUFS5;COX7A2L;NDUFAB1;RPS6;NDUFA8;COX2;ARID1A;SMARCD2;PRKAA1;NDUFB10;ATP5F1C;ATP5F1E;NDUFA4,KEGG_2021_Human,Thermogenesis,0.16520561914164839,ns,False
167,prerank,KEGG_2021_Human__Colorectal cancer,-0.27510012772517917,-0.9337210700010752,0.5846994535519126,0.7043352584846186,1.0,12/34,21.92%,FOS;GADD45A;JUN;RAC1;AKT1;MAPK3;SOS2;GRB2;SMAD4;PIK3CB;BBC3;KRAS,KEGG_2021_Human,Colorectal cancer,0.15222057061372285,ns,False
169,prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.27129201741723385,-0.9279117077173528,0.592896174863388,0.7099735905800871,1.0,8/35,9.84%,FOS;PTPRC;JUN;PPP3CA;AKT1;MAPK13;MAPK14;MAPK3,KEGG_2021_Human,T cell receptor signaling pathway,0.14875780575790348,ns,False
173,prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,-0.29053755321091984,-0.9080832950466622,0.6056338028169014,0.7489170076011217,1.0,13/26,31.76%,RAC1;AKT1;MAPK13;MAPK14;MAPK3;SOS2;GRB2;PIK3CB;KRAS;RAF1;ALOX5;TNF;PIK3CA,KEGG_2021_Human,Fc epsilon RI signaling pathway,0.12556630665018273,ns,False
175,prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,-0.25845563685030915,-0.9054045169117717,0.5903954802259888,0.7470648677073183,1.0,11/36,14.56%,IL1B;JUN;CDKN1B;RAC1;AKT1;MAPK13;VEGFA;MAPK14;MAPK3;FN1;STAT5B,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,0.1266416867197664,ns,False
176,prerank,KEGG_2021_Human__Renal cell carcinoma,-0.26492936125762545,-0.90438144630932,0.6282420749279539,0.7415456261274457,1.0,11/33,22.50%,JUN;RAC1;AKT1;VEGFA;MAPK3;RAP1A;SOS2;GRB2;PIK3CB;KRAS;RBX1,KEGG_2021_Human,Renal cell carcinoma,0.1298621223621405,ns,False
177,prerank,KEGG_2021_Human__Non-small cell lung cancer,-0.2794949279795995,-0.9002072740228055,0.5959595959595959,0.7430065996754314,1.0,10/29,21.92%,GADD45A;AKT1;MAPK3;E2F2;STAT5B;SOS2;GRB2;RASSF5;PIK3CB;KRAS,KEGG_2021_Human,Non-small cell lung cancer,0.12900732864872108,ns,True
178,prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.2775859080454287,-0.8885794810260511,0.6266318537859008,0.7615221999398447,1.0,10/24,30.72%,TSPO;PRDX5;SCGB1A1;FIS1;ECH1;DHRS3;CTBP1;IDH1;CAT;VPS4B,MSigDB_Hallmark_2020,Pperoxisome,0.11831743156518125,ns,False
179,prerank,KEGG_2021_Human__Insulin signaling pathway,-0.24126422552921598,-0.8763402253494648,0.6896551724137931,0.7799603066871185,1.0,19/41,31.76%,CALM1;PYGL;AKT1;CALM2;MAPK3;FLOT2;MKNK2;EIF4EBP1;SOS2;GRB2;PIK3CB;KRAS;PPP1CA;RAF1;HK3;RPS6;PRKAA1;PPP1R3D;PIK3CA,KEGG_2021_Human,Insulin signaling pathway,0.10792749862412707,ns,False
181,prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.2379885539717806,-0.871651426417925,0.6831395348837209,0.7818647718346748,1.0,16/46,21.92%,ARHGDIB;CALM1;JUN;RAC1;AKT1;CALM2;MAPK13;MAPK14;MAPK3;MAP3K3;RAP1A;SORT1;SOS2;GRB2;PIK3CB;KRAS,KEGG_2021_Human,Neurotrophin signaling pathway,0.1068683542604302,ns,False
183,prerank,KEGG_2021_Human__Acute myeloid leukemia,-0.26275132161694414,-0.854396861416053,0.7029177718832891,0.8093514537308495,1.0,13/28,23.36%,RARA;AKT1;MAPK3;CSF1R;EIF4EBP1;STAT5B;PIM1;DUSP6;SOS2;GRB2;PIK3CB;KRAS;SPI1,KEGG_2021_Human,Acute myeloid leukemia,0.09186284888083057,ns,False
184,prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,-0.308102921997654,-0.8494852395614626,0.6788321167883211,0.8109504552920372,1.0,7/16,29.55%,ARHGDIB;GNAS;CREB5;RAB5B;DYNLL1;DYNC1I2;DYNC1LI1,KEGG_2021_Human,Vasopressin-regulated water reabsorption,0.09100567803366344,ns,False
185,prerank,KEGG_2021_Human__Ras signaling pathway,-0.22814331813066235,-0.846616431969693,0.770392749244713,0.8086409480242707,1.0,18/52,21.92%,RALBP1;CALM1;RASGRP2;RAC1;AKT1;CALM2;VEGFA;MAPK3;CSF1R;RAP1A;GNG10;SOS2;GRB2;RASSF5;ARF6;RAB5B;PIK3CB;KRAS,KEGG_2021_Human,Ras signaling pathway,0.09224427060719634,ns,False
188,prerank,KEGG_2021_Human__AMPK signaling pathway,-0.24604296738002068,-0.8257550692652565,0.7575757575757576,0.8394702071844237,1.0,14/33,34.46%,PPP2R5A;AKT1;CREB5;ADIPOR1;EIF4EBP1;PIK3CB;RAB2A;HMGCR;EEF2;PPP2R5C;PRKAA1;PIK3CA;AKT2;STK11,KEGG_2021_Human,AMPK signaling pathway,0.07599471237286817,ns,False
192,prerank,MSigDB_Hallmark_2020__E2F Targets,-0.23911428212799332,-0.7752233919728266,0.8421052631578947,0.9131688402736244,1.0,2/28,3.74%,HMGB2;CDKN1B,MSigDB_Hallmark_2020,E2F Targets,0.03944891620074904,ns,False
194,prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,-0.23061168396083598,-0.7583131046505854,0.8888888888888888,0.9268273846793325,1.0,10/31,25.90%,ACTB;NCOR1;AKT1;MAPK3;NOTCH1;NOTCH2;PIK3CB;KRAS;NCOA3;RAF1,KEGG_2021_Human,Thyroid hormone signaling pathway,0.03300114272903933,ns,False
196,prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.21256415841538984,-0.7382013733662943,0.8839285714285714,0.9405647088797395,1.0,8/37,15.36%,MARCKS;CDKN1B;MAPK14;SAP30;E2F2;HMGN2;LBR;NOTCH2,MSigDB_Hallmark_2020,G2-M Checkpoint,0.02661132053606366,ns,False
199,prerank,KEGG_2021_Human__TGF-beta signaling pathway,-0.2418359746282101,-0.7309496582686035,0.8709677419354839,0.939469919828008,1.0,7/19,29.95%,ROCK1;MAPK3;ID3;SMAD4;RBX1;BMPR2;TNF,KEGG_2021_Human,TGF-beta signaling pathway,0.027117120685165193,ns,True
204,prerank,KEGG_2021_Human__mRNA surveillance pathway,-0.19820377825952307,-0.6747708985255746,0.9461756373937678,0.9765441135604771,1.0,33/33,80.41%,PPP2R5A;PPP1CA;ACIN1;PAPOLA;PPP2R5C;PNN;PCF11;UPF2;ALYREF;FUS;PPP1CB;SMG7;PYM1;PPP2CB;ETF1;DAZAP1;PABPC1;RBM8A;SSU72;PPP2R2A;NXT1;PPP2CA;MAGOHB;PPP2R1A;PPP1CC;SAP18;EIF4A3;DDX39B;RNPS1;MAGOH;WDR33;SRRM1;FIP1L1,KEGG_2021_Human,mRNA surveillance pathway,0.010308133489115967,ns,False
205,prerank,KEGG_2021_Human__Endocytosis,-0.16065845533522613,-0.6727235902471731,0.996268656716418,0.9686482210209522,1.0,19/89,23.11%,ARPC1B;GRK2;ARPC2;GRK6;RAB11FIP1;ACAP1;SMAP2;ACTR2;ARAP3;ACTR3;SH3KBP1;ACAP2;RAB11FIP4;ARF6;RAB5B;CAPZA1;ARPC3;ARFGEF1;PSD4,KEGG_2021_Human,Endocytosis,0.013833914804207238,ns,False
206,prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,-0.15611483420222494,-0.6558223172641743,0.981549815498155,0.9694472975466337,1.0,8/86,9.23%,FOS;IL1B;JUN;RAC1;AKT1;CYTB;MAPK13;MAPK14,KEGG_2021_Human,Non-alcoholic fatty liver disease,0.013475795669147595,ns,False
207,prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.17562957589047934,-0.6355017337699047,0.98,0.9699059305813843,1.0,14/41,28.20%,RPS14;SERP1;VEGFA;TUBB2A;EIF4A1;EIF4EBP1;HERPUD1;DDIT4;YWHAZ;SPCS3;IFIT1;NABP1;EEF2;ATF4,MSigDB_Hallmark_2020,Unfolded Protein Response,0.013270385126050034,ns,False
218,prerank,KEGG_2021_Human__Prion disease,0.13326572868551953,0.518261888263526,1.0,0.9943233033557878,1.0,22/140,20.23%,IL1A;CCL5;CASP3;BAX;UQCRHL;PSMA5;DDIT3;CYCS;PSMA1;TUBA1C;EGR1;PSMD14;PSMA3;PSMA2;NDUFC2-KCTD14;C1QA;ATP5PF;SLC25A5;ATP5PO;ATP5MC1;NDUFS2;PRKCD,KEGG_2021_Human,Prion disease,0.002472382168063768,ns,False
217,prerank,KEGG_2021_Human__Alzheimer disease,0.1365085168671317,0.5412541655032198,1.0,1.0,1.0,25/163,20.11%,CSF1;FAS;IL1A;CASP3;TRAF2;EIF2AK2;UQCRHL;PSMA5;DDIT3;NFKB1;CYCS;PSMA1;TUBA1C;PSMD14;PSMA3;RELA;PSMA2;NDUFC2-KCTD14;ATP5PF;SLC25A5;ATP5PO;ATP5MC1;ADAM17;NDUFS2;TPTEP2-CSNK1E,KEGG_2021_Human,Alzheimer disease,-0.0,ns,False
216,prerank,KEGG_2021_Human__Huntington disease,0.14307395395848868,0.5571832164211685,1.0,1.0,1.0,34/139,29.98%,GPX1;SOD2;CASP3;TRAF2;BAX;UQCRHL;PSMA5;CYCS;PSMA1;TUBA1C;PSMD14;PSMA3;PSMA2;NDUFC2-KCTD14;ATP5PF;SLC25A5;ATP5PO;ATP5MC1;NDUFS2;COX8A;CLTA;NDUFS4;DCTN5;TUBA1B;COX5A;PSMC2;PSMA6;SEM1;BECN1;ATP5PD;PSMD12;NDUFA7;PSMB3;UQCRQ,KEGG_2021_Human,Huntington disease,-0.0,ns,False
215,prerank,KEGG_2021_Human__RNA transport,0.17541147131894133,0.580743624877788,0.9867060561299852,1.0,1.0,22/52,34.46%,UBE2I;EIF3CL;SUMO4;EIF3G;EIF1B;EIF2S2;SRRM1;TPR;EIF4E2;EIF2S3;POP7;EIF4B;EIF3D;MAGOH;RNPS1;DDX39B;EIF4A3;EIF3J;SAP18;EIF3I;FMR1;EIF5,KEGG_2021_Human,RNA transport,-0.0,ns,False
214,prerank,KEGG_2021_Human__Hippo signaling pathway,0.19429580665970567,0.5908564865217162,0.9857594936708861,1.0,1.0,7/31,24.98%,BIRC3;RASSF4;SMAD7;YWHAH;TPTEP2-CSNK1E;RASSF1;TGFB1,KEGG_2021_Human,Hippo signaling pathway,-0.0,ns,False
213,prerank,KEGG_2021_Human__Parkinson disease,0.1543967781420112,0.6011499239060741,0.9987405541561712,1.0,1.0,35/139,28.30%,UBE2L6;UBB;CASP3;BAX;UQCRHL;PSMA5;DDIT3;CYCS;PSMA1;TUBA1C;UBA7;PSMD14;UBE2L3;PSMA3;PSMA2;UBE2J1;NDUFC2-KCTD14;ATP5PF;SLC25A5;ATP5PO;ATP5MC1;NDUFS2;UBE2J2;COX8A;NFE2L2;UBC;NDUFS4;TUBA1B;XBP1;COX5A;PSMC2;PSMA6;SEM1;ATP5PD;PSMD12,KEGG_2021_Human,Parkinson disease,-0.0,ns,False
212,prerank,KEGG_2021_Human__Longevity regulating pathway,0.2058695134891545,0.6137375070705197,0.9654036243822076,1.0,1.0,5/29,15.63%,SOD2;BAX;RHEB;NFKB1;RELA,KEGG_2021_Human,Longevity regulating pathway,-0.0,ns,False
211,prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.21539081463044094,0.6189212683650551,0.9508716323296355,1.0,1.0,7/26,26.15%,SKIL;SKI;SMAD7;PPP1R15A;RHOA;TGFB1;KLF10,MSigDB_Hallmark_2020,TGF-beta Signaling,-0.0,ns,True
210,prerank,KEGG_2021_Human__Insulin resistance,0.2067728897826317,0.6252778252648249,0.9626749611197511,1.0,1.0,9/31,23.70%,NFKB1;CPT1A;NFKBIA;SOCS3;RELA;PRKCD;TNFRSF1A;PPP1R3B;MLX,KEGG_2021_Human,Insulin resistance,-0.0,ns,False
209,prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.17612136735298245,0.6268304065771461,0.9944903581267218,1.0,1.0,28/79,30.41%,ODC1;PSMA1;IFRD1;PSMD14;SNRPD1;UBE2L3;U2AF1;LDHA;PSMA2;DEK;CANX;HNRNPA3;SET;CNBP;HNRNPU;EIF2S2;CCT2;PCBP1;COX5A;PSMA6;CCT4;SRSF7;EIF3D;SERBP1;RPL14;HNRNPD;PSMB3;RNPS1,MSigDB_Hallmark_2020,Myc Targets V1,-0.0,ns,False
208,prerank,KEGG_2021_Human__Thyroid cancer,0.24437242606700738,0.6278297440703295,0.9364548494983278,1.0,1.0,7/16,26.06%,CDKN1A;BAX;BAK1;TPM3;RXRA;GADD45G;TPR,KEGG_2021_Human,Thyroid cancer,-0.0,ns,False
203,prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.17400773709144593,0.6871045218927676,0.9825,1.0,1.0,46/165,29.98%,SQSTM1;CASP1;GPX1;GABARAP;CASP3;TRAF2;BAX;UQCRHL;PSMA5;DDIT3;CYCS;PSMA1;TUBA1C;TANK;PSMD14;PSMA3;PSMA2;SETX;NDUFC2-KCTD14;HNRNPA3;ATP5PF;ATP5PO;ATP5MC1;NDUFS2;TNFRSF1A;COX8A;DERL1;NDUFS4;DCTN5;TPR;TUBA1B;XBP1;COX5A;PSMC2;PSMA6;SEM1;ACTG1;BECN1;ATP5PD;PSMD12;SRSF7;TBK1;MATR3;NDUFA7;PSMB3;UQCRQ,KEGG_2021_Human,Amyotrophic lateral sclerosis,-0.0,ns,False
202,prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.20844565670333187,0.6898219649100084,0.9524517087667161,1.0,1.0,6/45,10.85%,SQSTM1;ARHGDIA;CDKN1A;TRAF2;NFKBIB;DDIT3,MSigDB_Hallmark_2020,PI3K/AKT/mTOR  Signaling,-0.0,ns,True
201,prerank,KEGG_2021_Human__Cardiac muscle contraction,0.25982298824793926,0.6956090288314304,0.8693467336683417,1.0,1.0,9/19,34.15%,UQCRHL;ATP1B3;TPM4;COX8A;TPM3;COX5A;UQCRQ;COX6C;COX4I1,KEGG_2021_Human,Cardiac muscle contraction,-0.0,ns,False
200,prerank,KEGG_2021_Human__Purine metabolism,0.2745792101737042,0.7024356852953999,0.8604651162790697,1.0,1.0,6/15,25.87%,NUDT9;NT5C3A;PGM2;IMPDH1;PDE4B;XDH,KEGG_2021_Human,Purine metabolism,-0.0,ns,False
198,prerank,MSigDB_Hallmark_2020__Androgen Response,0.24392061096841317,0.7342979774758464,0.847457627118644,1.0,1.0,7/31,19.56%,B2M;ARID5B;UBE2I;SCD;TNFAIP8;UBE2J1;MYL12A,MSigDB_Hallmark_2020,Androgen Response,-0.0,ns,False
197,prerank,KEGG_2021_Human__Ferroptosis,0.28207862543982365,0.7368654991748734,0.82398753894081,1.0,1.0,7/18,28.26%,FTH1;GCLM;SLC3A2;ACSL5;PCBP1;HMOX1;PCBP2,KEGG_2021_Human,Ferroptosis,-0.0,ns,False
195,prerank,KEGG_2021_Human__Glycerophospholipid metabolism,0.27703914518301537,0.7566045402441711,0.8243021346469622,1.0,1.0,3/19,13.89%,CHPT1;PGS1;CEPT1,KEGG_2021_Human,Glycerophospholipid metabolism,-0.0,ns,False
193,prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.25168335455144897,0.7752224077683056,0.7993579454253612,0.9921878482492589,1.0,4/35,10.02%,RALGDS;SYK;PIK3R5;RHEB,KEGG_2021_Human,Phospholipase D signaling pathway,0.003406096258319148,ns,False
191,prerank,KEGG_2021_Human__Pancreatic cancer,0.2603593927511434,0.7891187807705844,0.785483870967742,0.9793611718183902,1.0,6/32,11.10%,RALGDS;STAT1;CDKN1A;BAX;BAK1;NFKB1,KEGG_2021_Human,Pancreatic cancer,0.009057118205576196,ns,False
190,prerank,KEGG_2021_Human__Oxidative phosphorylation,0.2272250259039668,0.8241879999104862,0.7857142857142857,0.9248810569588655,1.0,16/83,20.08%,ATP6V1F;ATP6V1B2;TCIRG1;COX17;ATP6V0E1;UQCRHL;ATP6V1C1;ATP6V1A;ATP6V1D;ATP6V0D1;NDUFC2-KCTD14;ATP5PF;ATP5PO;ATP5MC1;NDUFS2;ATP6V0B,KEGG_2021_Human,Oxidative phosphorylation,0.03391411550732073,ns,False
189,prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.2283430942951286,0.8255120060647375,0.8083916083916084,0.9326110972248628,1.0,15/81,17.17%,CSF1;IL4R;IBSP;SYK;IL7R;PIK3R5;CDKN1A;IFNAR2;RHEB;NFKB1;SPP1;RELA;ITGA5;PIK3AP1;YWHAH,KEGG_2021_Human,PI3K-Akt signaling pathway,0.030299421140964206,ns,False
187,prerank,KEGG_2021_Human__Salmonella infection,0.2234164764427765,0.8415673883464698,0.7918848167539267,0.9112044230067914,1.0,24/118,15.88%,CD14;RHOH;BIRC3;CASP1;DYNLT1;RIPK2;CASP3;TRAF2;BAX;MYL12B;NLRC4;BAK1;TNFSF10;NFKB1;CYCS;M6PR;TUBA1C;RAB5C;GSDMD;NFKBIA;RAB7A;RHOG;RELA;KPNA4,KEGG_2021_Human,Salmonella infection,0.04038418084864339,ns,True
186,prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.2085228209226737,0.8440641031981657,0.8135593220338984,0.916597284818793,1.0,37/193,21.61%,UBE2L6;CSF1;FAS;SQSTM1;IL1A;GPX1;UBB;GABARAP;CASP3;TRAF2;BAX;UQCRHL;PSMA5;BAK1;DDIT3;NFKB1;CYCS;PSMA1;TUBA1C;TANK;UBA7;PSMD14;UBE2L3;PSMA3;RELA;PSMA2;UBE2J1;NDUFC2-KCTD14;ATP5PF;SLC25A5;ATP5PO;ATP5MC1;NDUFS2;TPTEP2-CSNK1E;TNFRSF1A;UBE2J2;COX8A,KEGG_2021_Human,Pathways of neurodegeneration,0.03782143357384412,ns,False
182,prerank,KEGG_2021_Human__Mitophagy,0.28031999879209857,0.8681950075299747,0.6868852459016394,0.8752322084966266,1.0,7/35,15.63%,SQSTM1;UBB;GABARAP;USP15;CALCOCO2;RAB7A;RELA,KEGG_2021_Human,Mitophagy,0.057876708703773,ns,False
180,prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.2391520647351714,0.8750573603162572,0.6978319783197832,0.8706227204673146,1.0,19/93,20.08%,ATP6V1F;TCIRG1;COX17;ATP6V0E1;ALAS1;BAX;ATP6V1C1;CYCS;CPT1A;POR;ATP6V1D;LDHA;GRPEL1;ATP5PF;SLC25A5;ATP5PO;ATP5MC1;NDUFS2;ATP6V0B,MSigDB_Hallmark_2020,Oxidative Phosphorylation,0.06017000333434479,ns,False
174,prerank,MSigDB_Hallmark_2020__Myogenesis,0.3049959013643083,0.906813743451966,0.5894245723172629,0.8100736217586717,1.0,10/30,24.98%,BHLHE40;CDKN1A;BAG1;IFRD1;PDLIM7;SCD;KLF5;TPM3;SIRT2;TGFB1,MSigDB_Hallmark_2020,Myogenesis,0.09147550942928426,ns,False
172,prerank,KEGG_2021_Human__B cell receptor signaling pathway,0.29458239126523783,0.91809070494089,0.5990566037735849,0.7935337969253901,1.0,12/36,18.27%,NFKBIE;PTPN6;SYK;FCGR2B;NFKBIB;NFKB1;LYN;NFKBIA;RELA;CD81;PIK3AP1;VAV1,KEGG_2021_Human,B cell receptor signaling pathway,0.10043457173757578,ns,False
171,prerank,KEGG_2021_Human__Prolactin signaling pathway,0.3109628824896604,0.9219242794473347,0.5735294117647058,0.7941929365279023,1.0,7/26,15.63%,SOCS1;CISH;IRF1;STAT1;NFKB1;SOCS3;RELA,KEGG_2021_Human,Prolactin signaling pathway,0.10007397982640004,ns,False
170,prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.2992224654558089,0.9245142942230467,0.6150234741784038,0.7976342807406609,1.0,4/33,3.49%,BHLHE40;P2RY2;CHPT1;CISH,MSigDB_Hallmark_2020,Estrogen Response Early,0.09819618917913264,ns,False
168,prerank,KEGG_2021_Human__Spinocerebellar ataxia,0.2744882641484532,0.9292472589899641,0.5820029027576198,0.7968379079480633,1.0,15/51,29.77%,TRAF2;PSMA5;CYCS;PSMA1;PSMD14;PSMA3;PSMA2;SLC25A5;XBP1;PSMC2;PSMA6;SEM1;BECN1;PSMD12;PSMB3,KEGG_2021_Human,Spinocerebellar ataxia,0.0986300134133537,ns,False
166,prerank,MSigDB_Hallmark_2020__Protein Secretion,0.29040411354932794,0.9392079413866401,0.579250720461095,0.7834032987464931,1.0,5/39,12.32%,CD63;ABCA1;PPT1;M6PR;LAMP2,MSigDB_Hallmark_2020,Protein Secretion,0.10601460406159832,ns,False
163,prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.2594284282367906,0.9519928434324308,0.5428954423592494,0.7620552835269586,1.0,31/94,24.59%,BHLHE40;GGA2;SQSTM1;NAMPT;WARS1;TES;LGMN;GLRX;CDKN1A;NUPR1;NFKBIB;DDIT3;M6PR;IFRD1;PSMD14;ATP6V1D;PSMA3;SCD;CACYBP;LDHA;CANX;PPP1R15A;PRDX1;ATP5MC1;DAPP1;SLC9A3R1;CALR;EIF2S2;GTF2H1;TPI1;NIBAN1,MSigDB_Hallmark_2020,mTORC1 Signaling,0.11801352149531394,ns,True
162,prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,0.3014683547608932,0.9668895428680252,0.5214723926380368,0.736289671754232,1.0,10/41,15.63%,CD274;NFKBIE;PTPN6;BATF;STAT1;EML4;NFKBIB;NFKB1;NFKBIA;RELA,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.13295129151243953,ns,False
160,prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,0.3280602276412513,0.9687208380723976,0.4825949367088608,0.7416853143586203,1.0,9/26,15.63%,IL4R;NFKBIE;STAT1;HLA-DQA2;NFKBIB;NFKB1;NFKBIA;HLA-DRA;RELA,KEGG_2021_Human,Th1 and Th2 cell differentiation,0.12978032009317567,ns,False
159,prerank,KEGG_2021_Human__Spliceosome,0.2807570098634778,0.972490801957854,0.5056338028169014,0.7422697153394665,1.0,34/65,39.61%,SNRPD1;U2AF1;RBM17;HNRNPA3;SNRPC;PUF60;CWC15;HNRNPU;SMNDC1;LSM4;U2SURP;PCBP1;SNW1;SRSF7;MAGOH;DDX39B;SNU13;SNRPB;EIF4A3;LSM8;TXNL4A;WBP11;SF3B4;PRPF40A;PHF5A;SNRPF;PQBP1;HNRNPK;SF3B5;MAGOHB;BUD31;DHX38;LSM7;DHX15,KEGG_2021_Human,Spliceosome,0.12943825833356476,ns,False
156,prerank,KEGG_2021_Human__Complement and coagulation cascades,0.3803546326683551,0.9930348802486715,0.4628099173553719,0.7023147718525855,1.0,7/17,17.87%,CFB;C2;SERPING1;PLAUR;C3AR1;C1QA;ITGAX,KEGG_2021_Human,Complement and coagulation cascades,0.15346819693100391,ns,False
154,prerank,KEGG_2021_Human__Shigellosis,0.27116268205730076,1.0077720243340815,0.47354497354497355,0.6759675574783798,1.0,23/104,16.19%,CD14;SQSTM1;CASP1;RRAGC;CCL5;H3-3B;UBB;GABARAP;RIPK2;TRAF2;STING1;BAX;NFKBIB;MYL12B;NLRC4;NFKB1;CYCS;TRAF5;CALCOCO2;NFKBIA;U2AF1;RELA;ITGA5,KEGG_2021_Human,Shigellosis,0.1700741471740786,ns,False
150,prerank,KEGG_2021_Human__Hepatitis B,0.29933207365526526,1.0277991843233734,0.40620384047267355,0.6378189175820101,1.0,11/62,11.19%,IRF7;FAS;DDX58;EGR2;STAT1;CDKN1A;IFIH1;CASP3;BAX;NFKB1;CYCS,KEGG_2021_Human,Hepatitis B,0.19530260381423045,ns,True
148,prerank,MSigDB_Hallmark_2020__DNA Repair,0.324121744598457,1.0315243284319753,0.42251461988304095,0.6379860795671773,1.0,13/42,24.25%,CMPK2;COX17;NUDT9;NT5C3A;SDCBP;TAF12;TAF9;SEC61A1;EIF1B;POLE4;PDE4B;GTF2H1;TSG101,MSigDB_Hallmark_2020,DNA Repair,0.1951887971928114,ns,False
146,prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.3326995920638614,1.039373536691257,0.41379310344827586,0.6288157968460175,1.0,7/36,5.98%,SNX10;ISG20;CHPT1;CISH;PTPN6;FABP5;BATF,MSigDB_Hallmark_2020,Estrogen Response Late,0.20147655666826195,ns,False
145,prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.30009765540076183,1.0436398005239294,0.3923705722070845,0.6280236449747547,1.0,21/64,26.70%,SAR1B;TRAF2;BAG1;UBXN1;BAX;EIF2AK2;BAK1;DDIT3;SAR1A;SSR4;UBE2J1;CANX;PPP1R15A;UBE2J2;SEC61A1;NFE2L2;DERL1;CALR;DNAJC3;XBP1;UFD1,KEGG_2021_Human,Protein processing in endoplasmic reticulum,0.2020240048476008,ns,False
142,prerank,KEGG_2021_Human__mTOR signaling pathway,0.3236801365793026,1.0548316762953485,0.37613293051359514,0.6103561970301465,1.0,19/46,27.87%,FNIP2;RRAGC;ATP6V1F;ATP6V1B2;RHEB;ATP6V1C1;ATP6V1A;ATP6V1D;LAMTOR1;SLC3A2;FLCN;TNFRSF1A;LPIN2;RHOA;LAMTOR3;LAMTOR4;EIF4E2;ATP6V1G1;EIF4B,KEGG_2021_Human,mTOR signaling pathway,0.21441664161723317,ns,True
141,prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.3408770298043935,1.0555832164774654,0.3824,0.6178505330651789,1.0,8/35,17.17%,UBE2L6;PSME1;ODC1;CPT1A;CA4;LDHA;METAP1;YWHAH,MSigDB_Hallmark_2020,Fatty Acid Metabolism,0.20911657428989067,ns,False
140,prerank,MSigDB_Hallmark_2020__Hypoxia,0.30735612900984594,1.0715450636637533,0.3456973293768546,0.5885071549313865,1.0,11/64,7.17%,PLAC8;SDC4;ISG20;BHLHE40;ATF3;TNFAIP3;PLIN2;PNRC1;TES;GLRX;CDKN1A,MSigDB_Hallmark_2020,Hypoxia,0.230248252738422,ns,True
134,prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.31370822804438686,1.0969484736092343,0.299860529986053,0.5389543127809567,1.0,16/61,15.63%,B2M;ICAM1;NFKB2;IL1R2;EGR2;RELB;CDKN1A;HLA-DQA2;BAX;ETS2;IL15RA;NFKB1;EGR1;NFKBIA;HLA-DRA;RELA,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,0.2684480484460853,ns,True
130,prerank,KEGG_2021_Human__Amoebiasis,0.3749164655144008,1.1166011482426166,0.30393700787401573,0.503286463314778,1.0,11/29,19.10%,CD14;CXCL3;IL1R2;CASP3;NFKB1;RAB5C;RAB7A;RELA;CXCL1;PRDX1;TLR2,KEGG_2021_Human,Amoebiasis,0.298184750482566,ns,False
127,prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.31709219937455874,1.123357515628559,0.26353276353276356,0.49641360559196396,1.0,14/72,11.86%,B2M;FAS;TAP1;BST2;TAP2;LIMK2;CASP3;TRAF2;STING1;BAX;BAK1;NFKB1;CYCS;TRAF5,KEGG_2021_Human,Human immunodeficiency virus 1 infection,0.3041563239651324,ns,True
126,prerank,KEGG_2021_Human__Small cell lung cancer,0.3844772135306376,1.125932444266331,0.30288461538461536,0.4986825402568242,1.0,11/26,15.63%,BIRC3;CDKN1A;CASP3;TRAF2;BAX;BAK1;NFKB1;CYCS;TRAF5;NFKBIA;RELA,KEGG_2021_Human,Small cell lung cancer,0.30217583692071137,ns,True
120,prerank,KEGG_2021_Human__Viral myocarditis,0.44731916598621946,1.1573440907234172,0.28735632183908044,0.4387993445375289,1.0,6/16,14.99%,ICAM1;CD80;CASP3;HLA-DQA2;CYCS;HLA-DRA,KEGG_2021_Human,Viral myocarditis,0.35773402983011343,ns,False
118,prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.35541441206551605,1.1628892633207073,0.23493975903614459,0.434406056977979,1.0,9/44,13.30%,TMBIM6;FAS;CFB;GCH1;SAR1B;ALAS1;ETS2;PSMB10;POR,MSigDB_Hallmark_2020,Xenobiotic Metabolism,0.3621041279547195,ns,False
114,prerank,KEGG_2021_Human__Cell adhesion molecules,0.44069006179218057,1.1724739472364334,0.2694214876033058,0.4214995365926222,1.0,4/18,2.97%,CD274;ICAM1;SDC4;CD80,KEGG_2021_Human,Cell adhesion molecules,0.3752028985134445,ns,False
113,prerank,KEGG_2021_Human__p53 signaling pathway,0.4285930332120967,1.17331588860972,0.2699490662139219,0.42720078470098816,1.0,6/21,11.19%,FAS;SHISA5;CDKN1A;CASP3;BAX;CYCS,KEGG_2021_Human,p53 signaling pathway,0.3693679582477675,ns,False
111,prerank,KEGG_2021_Human__Osteoclast differentiation,0.3412188800644775,1.1794316893453645,0.21030640668523676,0.4221204903458735,1.0,18/60,15.63%,CSF1;SOCS1;SQSTM1;NFKB2;IL1A;SYK;RELB;STAT1;IRF9;FCGR2B;IFNAR2;TRAF2;NFKB1;FCGR3B;LCP2;NFKBIA;SOCS3;RELA,KEGG_2021_Human,Osteoclast differentiation,0.3745635660446911,ns,False
110,prerank,KEGG_2021_Human__Inflammatory bowel disease,0.43314052210119286,1.1798100588980773,0.2474747474747475,0.4286987241931473,1.0,12/20,24.98%,IL4R;IL1A;STAT1;HLA-DQA2;NFKB1;HLA-DRA;RELA;TLR2;NOD2;STAT6;IFNGR1;TGFB1,KEGG_2021_Human,Inflammatory bowel disease,0.3678478089472646,ns,True
108,prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.36227258613498353,1.1964054766033905,0.20588235294117646,0.4010706593913205,1.0,10/46,7.27%,NFKB2;CASP1;CLEC7A;EGR2;CLEC4E;IRF1;SYK;RELB;STAT1;IRF9,KEGG_2021_Human,C-type lectin receptor signaling pathway,0.3967791079772807,ns,False
103,prerank,KEGG_2021_Human__Apoptosis,0.3622597910606485,1.23049285147326,0.15892053973013492,0.3401672860700873,1.0,18/56,15.63%,FAS;BIRC3;CTSB;LMNB1;CTSD;CASP3;TRAF2;BAX;BCL2A1;BAK1;TNFSF10;DDIT3;NFKB1;CYCS;TUBA1C;CFLAR;NFKBIA;RELA,KEGG_2021_Human,Apoptosis,0.4683074548692113,ns,True
101,prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3780623528168653,1.2526704463805594,0.14771048744460857,0.30561335392739775,1.0,18/51,20.60%,CXCL10;PSMB8;TNFAIP3;BIRC3;CFB;MAFB;IL7R;CSF2RA;GLRX;PLAUR;SPP1;RETN;INHBA;C3AR1;LAT2;PPP1R15A;ADAM17;IL10RA,MSigDB_Hallmark_2020,KRAS Signaling Up,0.5148276729684946,ns,False
96,prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.3548912787866725,1.2827982571328096,0.07818930041152264,0.26211782863839206,1.0,18/83,11.86%,B2M;CCL3L3;CCL4L2;FAS;TAP1;TAP2;CCL5;CCR1;CDKN1A;CASP3;TRAF2;STING1;BAX;RHEB;BAK1;NFKB1;CYCS;TRAF5,KEGG_2021_Human,Human cytomegalovirus infection,0.5815034383592319,ns,True
95,prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.3577905203610909,1.2835715610318623,0.08757062146892655,0.26623336235430656,1.0,23/80,14.07%,ICAM1;IRF7;FAS;CXCL3;SYK;PIK3R5;UBB;GABARAP;CCR1;STAT1;CDKN1A;IRF9;CASP3;IFNAR2;TRAF2;BAX;EIF2AK2;BAK1;NFKB1;CYCS;LYN;NFKBIA;RCAN1,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,0.5747375229465831,ns,True
94,prerank,MSigDB_Hallmark_2020__p53 Pathway,0.3531587926174057,1.2836307726636438,0.11533242876526459,0.2714520645973674,1.0,21/82,14.53%,RALGDS;SOCS1;FAS;TAP1;ATF3;TRAFD1;CASP1;IL1A;DRAM1;RNF19B;CDKN1A;CTSD;NUPR1;BAX;BAK1;DDIT3;IER3;PTPRE;TXNIP;GM2A;PRMT2,MSigDB_Hallmark_2020,p53 Pathway,0.5663068508591609,ns,False
93,prerank,MSigDB_Hallmark_2020__Complement,0.35685416321649277,1.2876612351258692,0.08333333333333333,0.27053514292988323,1.0,28/81,19.19%,IRF7;PSMB9;TNFAIP3;CASP1;CFB;CTSB;CCL5;CEBPB;C2;IRF1;EHD1;PIK3R5;LGMN;CTSD;CASP3;OLR1;SERPING1;LAMP2;USP15;LCP2;LYN;PLAUR;RHOG;IRF2;PPP4C;C1QA;CXCL1;VCPIP1,MSigDB_Hallmark_2020,Complement,0.5677763113737521,ns,False
91,prerank,KEGG_2021_Human__Staphylococcus aureus infection,0.4634231009229668,1.2945748609500227,0.14093959731543623,0.2648967414614455,1.0,11/22,17.41%,ICAM1;CFB;C2;FCGR2B;HLA-DQA2;FCAR;FCGR3B;HLA-DRA;PTAFR;C3AR1;C1QA,KEGG_2021_Human,Staphylococcus aureus infection,0.5769233839980402,ns,True
89,prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,0.41373039713693466,1.3154352626884858,0.11432926829268293,0.23829242622526978,1.0,12/40,14.93%,ICAM1;FAS;PTPN6;SYK;CASP3;IFNAR2;SH3BP2;HCST;TNFSF10;FCGR3B;LCP2;SH2D1B,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,0.6228897608463426,ns,False
88,prerank,KEGG_2021_Human__Autophagy,0.3943446183455349,1.3181810986821638,0.09198813056379822,0.23917815194280642,1.0,13/52,14.71%,SQSTM1;CTSB;RRAGC;GABARAP;CTSD;VMP1;RHEB;LAMP1;LAMP2;CFLAR;SH3GLB1;TANK;RAB7A,KEGG_2021_Human,Autophagy,0.6212784940984926,ns,False
85,prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.4711642985549583,1.3299637196935246,0.11363636363636363,0.226849207823673,1.0,12/23,26.18%,NFKBIE;TRAF2;NFKBIB;NFKB1;CPT1A;NFKBIA;SOCS3;RELA;TNFRSF1A;RXRA;ACSL5;ADIPOR2,KEGG_2021_Human,Adipocytokine signaling pathway,0.6442627329878178,ns,True
80,prerank,KEGG_2021_Human__Viral carcinogenesis,0.3923554744966582,1.3494008685351477,0.059420289855072465,0.2049803551891888,0.998,19/64,17.17%,IRF7;NFKB2;EGR2;SYK;CDKN1A;IRF9;CASP3;TRAF2;BAX;EIF2AK2;BAK1;NFKB1;TRAF5;LYN;NFKBIA;RELA;REL;ATP6V0D1;YWHAH,KEGG_2021_Human,Viral carcinogenesis,0.6882877586600779,ns,False
76,prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,0.4129345600496601,1.3761563316548906,0.051470588235294115,0.17485985880187216,0.991,14/51,11.10%,CD14;BIRC3;LMO2;IL1R2;CEBPB;H3-3B;PML;CDKN1A;NUPR1;BAX;BCL2A1;BAK1;DDIT3;NFKB1,KEGG_2021_Human,Transcriptional misregulation in cancer,0.7573098766372783,ns,False
75,prerank,KEGG_2021_Human__Tuberculosis,0.3870786522375371,1.3795529289645259,0.05532503457814661,0.1749864267152389,0.99,25/77,15.97%,CD14;CD74;CLEC7A;IL1A;CEBPB;CLEC4E;SYK;RIPK2;TCIRG1;STAT1;CTSD;CASP3;FCGR2B;HLA-DQA2;BAX;NFKB1;CYCS;LAMP1;FCGR3B;LAMP2;RAB5C;RAB7A;HLA-DRA;RELA;ATP6V0D1,KEGG_2021_Human,Tuberculosis,0.756995637206792,ns,False
72,prerank,KEGG_2021_Human__Chemokine signaling pathway,0.4007982401462009,1.3909472996897916,0.05150214592274678,0.16620260126127556,0.987,21/68,18.52%,CCL3L3;CXCL10;CCL4L2;CXCL16;CXCL3;CCL5;RAP1B;PIK3R5;FGR;CCR1;STAT1;CCL8;NFKBIB;NFKB1;LYN;NFKBIA;CCL2;RELA;STAT2;VAV1;CXCL1,KEGG_2021_Human,Chemokine signaling pathway,0.7793621832921168,ns,False
71,prerank,KEGG_2021_Human__Vibrio cholerae infection,0.4971974996385525,1.3913550380895596,0.09076175040518639,0.16984676359482836,0.987,10/22,21.70%,ATP6V1F;ATP6V1B2;TCIRG1;ATP6V0E1;ATP6V1C1;ATP6V1A;ATP6V1D;ATP6V0D1;ATP6V0B;SEC61A1,KEGG_2021_Human,Vibrio cholerae infection,0.7699427241327725,ns,True
67,prerank,KEGG_2021_Human__Toxoplasmosis,0.44380038506122194,1.4045238519332262,0.05623100303951368,0.15885046848846726,0.983,16/40,20.97%,SOCS1;BIRC3;IRGM;PIK3R5;STAT1;CASP3;HLA-DQA2;NFKBIB;NFKB1;CYCS;NFKBIA;HLA-DRA;RELA;TLR2;IL10RA;TNFRSF1A,KEGG_2021_Human,Toxoplasmosis,0.7990114999954353,ns,False
65,prerank,KEGG_2021_Human__Legionellosis,0.477956240791391,1.4290290719762226,0.05572755417956656,0.13618096475957422,0.971,14/32,19.10%,CD14;NFKB2;CASP1;CXCL3;SAR1B;CASP3;NLRC4;NFKB1;CYCS;NFKBIA;SAR1A;RELA;CXCL1;TLR2,KEGG_2021_Human,Legionellosis,0.8658835934336686,ns,False
64,prerank,MSigDB_Hallmark_2020__Apoptosis,0.4052340744945366,1.4379303850077305,0.028328611898016998,0.13094246925982755,0.965,27/76,15.63%,CD14;FAS;TAP1;ISG20;ATF3;SQSTM1;BIRC3;CASP1;IL1A;IRF1;GPX1;GCH1;CD38;PPT1;CDKN1A;SOD2;CASP3;CD69;BAX;TNFSF10;DDIT3;IER3;CFLAR;TXNIP;IFITM3;SMAD7;RELA,MSigDB_Hallmark_2020,Apoptosis,0.882919473588101,ns,True
63,prerank,KEGG_2021_Human__Lipid and atherosclerosis,0.39874740679345644,1.4397315241075406,0.026499302649930265,0.13260342864831928,0.964,25/83,15.63%,CCL3L3;ICAM1;CD14;IRF7;FAS;CASP1;CXCL3;CCL5;ABCA1;RAP1B;SOD2;CASP3;ABCG1;TRAF2;OLR1;BAX;TNFSF10;DDIT3;NFKB1;CYCS;LYN;TANK;NFKBIA;CCL2;RELA,KEGG_2021_Human,Lipid and atherosclerosis,0.8774452464908639,ns,False
60,prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.4525413455842864,1.4607852735827613,0.04154302670623145,0.1164750023837211,0.94,19/42,28.42%,UBE2L6;SOCS1;BIRC3;UBB;PML;UBA7;SOCS3;UBE2I;UBE2L3;UBE2J1;UBE2J2;HERC4;UBC;ELOC;UBE2Q1;ELOB;UBE2F;RNF7;UBE2A,KEGG_2021_Human,Ubiquitin mediated proteolysis,0.9337672719916804,ns,False
58,prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,0.4580820888271354,1.4743338827119794,0.04698972099853157,0.10685546624399393,0.934,14/42,15.63%,CCL3L3;CXCL10;CD14;IRF7;CCL4L2;MAP3K8;CD80;CCL5;STAT1;IFNAR2;NFKB1;SPP1;NFKBIA;RELA,KEGG_2021_Human,Toll-like receptor signaling pathway,0.9712032563835643,ns,False
56,prerank,MSigDB_Hallmark_2020__UV Response Up,0.4457505171542545,1.501138185274197,0.019746121297602257,0.08919867979531781,0.896,17/54,13.98%,ICAM1;TMBIM6;TAP1;ATF3;SQSTM1;IRF1;ATP6V1F;GCH1;PPT1;SOD2;CASP3;ALAS1;CNP;BAK1;ATP6V1C1;LYN;NFKBIA,MSigDB_Hallmark_2020,UV Response Up,1.0496415734473241,ns,False
55,prerank,KEGG_2021_Human__Systemic lupus erythematosus,0.5487797216401694,1.502122512117731,0.05040650406504065,0.09127655145839499,0.895,12/20,25.44%,CD80;C2;H3-3B;TRIM21;HLA-DQA2;FCGR3B;SNRPD1;HLA-DRA;C1QA;MACROH2A1;C4A;H3-3A,KEGG_2021_Human,Systemic lupus erythematosus,1.0396407764654056,ns,False
52,prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.43437385950262647,1.520154512169646,0.015602836879432624,0.08159793627938537,0.864,19/65,13.67%,CXCL10;CSF1;SOCS1;RHOH;IL4R;BHLHE40;MAP3K8;PLIN2;IL1R2;CISH;CST7;GBP4;BATF;CASP3;ODC1;TNFRSF9;TNFSF10;SPP1;IFITM3,MSigDB_Hallmark_2020,IL-2/STAT5 Signaling,1.0883208249937966,ns,True
47,prerank,KEGG_2021_Human__Human papillomavirus infection,0.4232016016795929,1.5440033170581096,0.010899182561307902,0.06839788712204095,0.817,27/90,16.19%,ISG15;FAS;MX1;IBSP;IRF1;ATP6V1F;OASL;ATP6V1B2;TCIRG1;STAT1;CDKN1A;IRF9;CASP3;IFNAR2;ATP6V0E1;BAX;EIF2AK2;RHEB;BAK1;ATP6V1C1;NFKB1;ATP6V1A;SPP1;ATP6V1D;RELA;ATP6V0D1;ITGA5,KEGG_2021_Human,Human papillomavirus infection,1.1649573138560732,ns,True
44,prerank,KEGG_2021_Human__TNF signaling pathway,0.4812519271182147,1.5622257459410336,0.008658008658008658,0.06062973013565466,0.775,20/45,15.63%,ICAM1;CXCL10;CSF1;FAS;TNFAIP3;BIRC3;MAP3K8;CXCL3;CCL5;CEBPB;IRF1;CASP3;TRAF2;NFKB1;TRAF5;CFLAR;NFKBIA;SOCS3;CCL2;RELA,KEGG_2021_Human,TNF signaling pathway,1.217314364815617,ns,False
43,prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.49416679153071863,1.5783229673757657,0.016541353383458645,0.05373939489854195,0.714,11/40,10.55%,SOCS1;IL4R;CISH;PTPN6;IL7R;CSF2RA;STAT1;CDKN1A;IRF9;IFNAR2;IL15RA,KEGG_2021_Human,JAK-STAT signaling pathway,1.269707227997821,ns,True
41,prerank,KEGG_2021_Human__Lysosome,0.4737051303650822,1.5913323417934404,0.005873715124816446,0.04956246749119571,0.684,20/51,22.72%,GGA2;CD63;CTSB;LGMN;PPT1;TCIRG1;LITAF;CTSD;M6PR;LAMP1;LAMP2;LAPTM4A;GM2A;CD164;NPC2;ATP6V0D1;CTSZ;ATP6V0B;GNS;CLTA,KEGG_2021_Human,Lysosome,1.3048470801988294,*,False
40,prerank,KEGG_2021_Human__Hematopoietic cell lineage,0.547857139783651,1.5913843942424981,0.028662420382165606,0.05146871624085708,0.684,9/25,9.32%,CD14;CSF1;IL4R;IL1A;IL1R2;CD38;IL7R;CSF2RA;HLA-DQA2,KEGG_2021_Human,Hematopoietic cell lineage,1.28845666401066,ns,False
38,prerank,KEGG_2021_Human__Phagosome,0.4584038352953898,1.6132972659418727,0.0,0.042840137341654566,0.617,30/69,20.08%,CD14;TAP1;TAP2;CLEC7A;ATP6V1F;ATP6V1B2;TCIRG1;FCGR2B;ATP6V0E1;OLR1;HLA-DQA2;FCAR;ATP6V1C1;M6PR;LAMP1;FCGR3B;MARCO;LAMP2;TUBA1C;ATP6V1A;RAB5C;RAB7A;HLA-DRA;ATP6V1D;ATP6V0D1;ITGA5;CANX;MSR1;TLR2;ATP6V0B,KEGG_2021_Human,Phagosome,1.368149145528625,*,False
37,prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.5719415862394094,1.632121732825628,0.024,0.03819155353411638,0.567,7/23,15.67%,ATF3;CXCL16;PNRC1;FABP5;LGMN;PLAUR;SCD,MSigDB_Hallmark_2020,Cholesterol Homeostasis,1.4180326752854502,*,False
36,prerank,KEGG_2021_Human__Rheumatoid arthritis,0.5277082101251949,1.6344793273778089,0.004615384615384616,0.0389306210440754,0.56,21/37,20.08%,CCL3L3;ICAM1;CSF1;CD80;CXCL3;IL1A;CCL5;ATP6V1F;ATP6V1B2;TCIRG1;ATP6V0E1;HLA-DQA2;ATP6V1C1;ATP6V1A;HLA-DRA;CCL2;ATP6V1D;ATP6V0D1;CXCL1;TLR2;ATP6V0B,KEGG_2021_Human,Rheumatoid arthritis,1.409708668106559,*,False
35,prerank,KEGG_2021_Human__Measles,0.4864552413673572,1.6587970255406423,0.0029411764705882353,0.03182390542967433,0.473,19/57,11.19%,IRF7;FAS;MX1;DDX58;TNFAIP3;IL1A;SLAMF1;STAT1;IRF9;IFIH1;CASP3;FCGR2B;IFNAR2;BAX;EIF2AK2;NFKBIB;BAK1;NFKB1;CYCS,KEGG_2021_Human,Measles,1.49724652480007,*,False
33,prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.6408567295038909,1.691174953554761,0.0049586776859504135,0.023427636944367718,0.365,10/18,22.72%,ATP6V1F;ATP6V1B2;TCIRG1;ATP6V0E1;ATP6V1C1;ATP6V1A;ATP6V1D;ATP6V0D1;ATP6V0B;CLTA,KEGG_2021_Human,Synaptic vesicle cycle,1.63027151480796,*,False
31,prerank,KEGG_2021_Human__Necroptosis,0.5009564383641099,1.6992369631136728,0.0014347202295552368,0.022404029422490725,0.345,18/57,13.21%,FTH1;FAS;SQSTM1;TNFAIP3;BIRC3;CASP1;IL1A;ZBP1;STAT1;IRF9;IFNAR2;TRAF2;BAX;EIF2AK2;TNFSF10;TRAF5;CFLAR;CHMP5,KEGG_2021_Human,Necroptosis,1.649673865657958,*,False
30,prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.5720513008486883,1.7355605626380315,0.0015337423312883436,0.01593458707147278,0.27,18/31,20.08%,CXCL3;CCL5;ATP6V1F;ATP6V1B2;TCIRG1;CASP3;ATP6V0E1;ATP6V1C1;NFKB1;ATP6V1A;LYN;NFKBIA;ATP6V1D;RELA;ATP6V0D1;CXCL1;ADAM17;ATP6V0B,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,1.797659186341763,*,True
28,prerank,KEGG_2021_Human__NF-kappa B signaling pathway,0.5398441641338427,1.7562593565259157,0.001483679525222552,0.013119476688845921,0.227,19/44,15.63%,ICAM1;CD14;CCL4L2;DDX58;TNFAIP3;BIRC3;NFKB2;CXCL3;SYK;RELB;TRAF2;BCL2A1;NFKB1;TRAF5;CFLAR;LYN;NFKBIA;UBE2I;RELA,KEGG_2021_Human,NF-kappa B signaling pathway,1.8820834878017596,*,False
25,prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,0.6213578618558124,1.79003583142362,0.0030959752321981426,0.009438899518219464,0.162,10/27,10.82%,CCL3L3;CXCL10;CCL4L2;CSF1;CXCL3;CCL5;CCR1;CCL8;TNFRSF14;TNFSF10,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,2.025078637166419,**,True
23,prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.4956402294072022,1.8105663977409268,0.0,0.0076162346643180055,0.125,32/84,15.21%,B2M;ICAM1;IRF7;SRGN;CSF1;SOCS1;CD74;FAS;TAP1;IL4R;TAP2;WARS1;GBP2;CD80;CCL5;CD47;C2;PTPN6;RIPK2;FGR;CCR1;STAT1;FCGR2B;IFNAR2;TRAF2;PSMB10;LCP2;LYN;DYRK3;INHBA;HLA-DRA;CCL2,MSigDB_Hallmark_2020,Allograft Rejection,2.1182596833409715,**,False
21,prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,0.5099358240725579,1.8328275480773588,0.0,0.0064083597672439695,0.101,30/77,15.63%,IRF7;TNFAIP3;BIRC3;NAMPT;GBP7;CASP1;CTSB;GBP2;CXCL3;CCL5;GBP4;GABARAP;RIPK2;IFI16;STAT1;IRF9;IFNAR2;TRAF2;STING1;NFKBIB;NLRC4;NFKB1;TRPV2;TRAF5;TXNIP;TANK;GSDMD;NFKBIA;CCL2;RELA,KEGG_2021_Human,NOD-like receptor signaling pathway,2.1932531148166206,**,False
17,prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.5755002865484924,1.9210639807926109,0.0,0.0018381684371734672,0.031,22/56,10.82%,CCL3L3;CXCL10;CCL4L2;CSF1;IL1RN;FAS;IL4R;CXCL16;CXCL3;IL1A;IL1R2;CCL5;IL7R;CSF2RA;EBI3;CCR1;CCL8;TNFRSF14;IFNAR2;TNFRSF9;IL15RA;TNFSF10,KEGG_2021_Human,Cytokine-cytokine receptor interaction,2.7356146953528793,**,True
16,prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,0.6800496691224888,1.926155961385157,0.0,0.001630230831158369,0.026,12/22,15.63%,CXCL10;IRF7;CCL4L2;DDX58;CASP1;CCL5;ZBP1;STING1;NFKBIB;NFKB1;NFKBIA;RELA,KEGG_2021_Human,Cytosolic DNA-sensing pathway,2.787750897681514,**,True
15,prerank,KEGG_2021_Human__Epstein-Barr virus infection,0.5264268162065349,1.9269770697044748,0.0,0.0017660834004215667,0.026,33/91,15.63%,B2M;ISG15;ICAM1;CXCL10;IRF7;FAS;TAP1;DDX58;TNFAIP3;NFKB2;TAP2;NFKBIE;SYK;RELB;STAT1;CDKN1A;IRF9;CASP3;IFNAR2;TRAF2;HLA-DQA2;BAX;EIF2AK2;NFKBIB;BAK1;NFKB1;CYCS;TRAF5;LYN;NFKBIA;PSMD14;HLA-DRA;RELA,KEGG_2021_Human,Epstein-Barr virus infection,2.752988791422302,**,True
14,prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.5912005688663822,1.928731313243903,0.0,0.0018578279926512581,0.025,19/48,10.55%,CXCL10;CD14;CSF1;SOCS1;FAS;IL4R;MAP3K8;CXCL3;IL1R2;IRF1;CD38;PIK3R5;CSF2RA;EBI3;CCR1;STAT1;IRF9;BAK1;IL15RA,MSigDB_Hallmark_2020,IL-6/JAK/STAT3 Signaling,2.730994497716134,**,True
13,prerank,KEGG_2021_Human__Hepatitis C,0.5569987461048259,1.9343379645466268,0.0,0.0018165429261478969,0.023,24/63,17.47%,CXCL10;RSAD2;IRF7;FAS;MX1;DDX58;STAT1;CDKN1A;IRF9;CASP3;IFNAR2;TRAF2;BAX;EIF2AK2;BAK1;NFKB1;CYCS;CFLAR;NFKBIA;SOCS3;RELA;CD81;YWHAH;STAT2,KEGG_2021_Human,Hepatitis C,2.7407543350052905,**,True
12,prerank,KEGG_2021_Human__Antigen processing and presentation,0.6931117150524678,1.9507933593973172,0.0,0.00142968656224603,0.016,9/23,9.32%,B2M;CD74;TAP1;TAP2;CTSB;PSME1;PSME2;LGMN;HLA-DQA2,KEGG_2021_Human,Antigen processing and presentation,2.844759164777947,**,False
11,prerank,KEGG_2021_Human__Proteasome,0.6274492109476049,1.9526207257558277,0.0,0.0016083973825267838,0.016,11/36,16.43%,PSMB8;PSMB9;PSME1;PSME2;PSMA5;PSMA1;PSMB10;POMP;PSMD14;PSMA3;PSMA2,KEGG_2021_Human,Proteasome,2.793606642330566,**,False
9,prerank,KEGG_2021_Human__Influenza A,0.5831842662826481,2.0235420126327783,0.0,0.0007568928858949571,0.007,30/69,15.63%,ICAM1;CXCL10;RSAD2;IRF7;FAS;MX1;DDX58;CASP1;IL1A;CCL5;PML;STAT1;IRF9;IFIH1;CASP3;IFNAR2;HLA-DQA2;BAX;EIF2AK2;NFKBIB;BAK1;TNFSF10;NFKB1;CYCS;CALCOCO2;NFKBIA;SOCS3;HLA-DRA;CCL2;RELA,KEGG_2021_Human,Influenza A,3.1209655767168965,***,True
7,prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,0.6939821784061346,2.071951257338357,0.0,0.00025229762863165233,0.002,14/27,15.63%,ISG15;CXCL10;IRF7;DDX58;DHX58;AZI2;IFIH1;TRAF2;STING1;NFKBIB;NFKB1;TANK;NFKBIA;RELA,KEGG_2021_Human,RIG-I-like receptor signaling pathway,3.5980868314365586,***,False
6,prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,0.5896954094890655,2.0773318138649604,0.0,0.0003027571543579828,0.002,34/71,16.19%,B2M;IRF7;CD74;FAS;TAP1;BST2;DDX58;BIRC3;TAP2;CCL5;SYK;PML;STAT1;IRF9;IFIH1;CASP3;TNFRSF14;IFNAR2;TRAF2;HLA-DQA2;STING1;BAX;EIF2AK2;RHEB;BAK1;NFKB1;CYCS;TRAF5;NFKBIA;SOCS3;HLA-DRA;CCL2;RELA;ITGA5,KEGG_2021_Human,Herpes simplex virus 1 infection,3.518905585388934,***,True
5,prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.5439333656025018,2.092667285710747,0.0,0.0,0.0,62/120,16.06%,ICAM1;CXCL10;CCRL2;SDC4;CSF1;TAP1;BHLHE40;ATF3;TNFAIP2;DDX58;SQSTM1;TNFAIP3;IFIT2;BIRC3;NAMPT;NFKB2;MAP3K8;CD80;CXCL3;NFKBIE;IL1A;CCL5;PNRC1;CEBPB;EGR2;IRF1;GCH1;EHD1;ABCA1;DRAM1;IL7R;RIPK2;RNF19B;RELB;SLC2A6;CDKN1A;LITAF;TNIP2;IFIH1;ZC3H12A;SOD2;TNFRSF9;CD69;OLR1;BCL2A1;ETS2;IL15RA;IER3;NFKB1;PTPRE;CFLAR;EGR1;TANK;PLAUR;NFKBIA;RCAN1;SOCS3;INHBA;CCL2;RELA;REL;TNFAIP8,MSigDB_Hallmark_2020,TNF-alpha Signaling via NF-kB,5.0,****,False
3,prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.6023623906572332,2.2177231582236496,0.0,0.0,0.0,49/88,16.34%,RTP4;ICAM1;CXCL10;CCRL2;CD14;NMI;IRF7;CSF1;BST2;IL4R;P2RY2;NAMPT;IL1A;CCL5;IRF1;RGS1;FFAR2;SLAMF1;GCH1;ABCA1;IL7R;PIK3R5;RIPK2;SLC28A2;CLEC5A;EBI3;CDKN1A;TNFRSF9;CD69;LY6E;OLR1;EIF2AK2;IL15RA;TNFSF10;NFKB1;MARCO;PTPRE;SEMA4D;LCP2;LYN;PLAUR;NFKBIA;INHBA;RHOG;CCL2;RELA;PTAFR;ITGA5;C3AR1,MSigDB_Hallmark_2020,Inflammatory Response,5.0,****,True
2,prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.8054079741099207,2.8123696366191995,0.0,0.0,0.0,64/77,15.85%,B2M;ISG15;RTP4;CXCL10;PSMB8;CCRL2;RSAD2;TMEM140;NMI;IRF7;UBE2L6;CSF1;CD74;IFIT3;TAP1;ISG20;HERC6;MX1;BST2;PSMB9;IL4R;IFIT2;TRAFD1;WARS1;OGFR;CASP1;DHX58;GBP2;LGALS3BP;CMPK2;PARP14;PSME1;CD47;PARP9;IRF1;IFI44;OASL;GBP4;PSME2;RIPK2;SP110;IFI27;DDX60;IRF9;IFIH1;TRIM26;EPSTI1;TRIM21;LY6E;EIF2AK2;CNP;HELZ2;SAMD9;TXNIP;PARP12;IFI44L;IFITM3;UBA7;IFI35;MOV10;PSMA3;SAMD9L;CMTR1;TENT5A,MSigDB_Hallmark_2020,Interferon Alpha Response,5.0,****,True
1,prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.7369176404020035,2.8176787214679595,0.0,0.0,0.0,91/133,16.58%,B2M;CD274;ISG15;RTP4;ICAM1;CXCL10;PSMB8;RSAD2;NMI;IRF7;UBE2L6;SOCS1;CD74;IFIT3;FAS;TAP1;ISG20;HERC6;MX1;BST2;PSMB9;IL4R;TNFAIP2;DDX58;TNFAIP3;IFIT2;NAMPT;TRAFD1;WARS1;OGFR;CASP1;DHX58;CFB;LGALS3BP;CMPK2;CCL5;PARP14;PSME1;IRF1;NLRC5;PTPN6;ZBP1;GCH1;IFI44;OASL;CD38;GBP4;PSME2;RIPK2;SP110;IFI27;RNF213;DDX60;PELI1;PML;STAT1;CDKN1A;IRF9;GBP6;ARID5B;IFIH1;TRIM26;SOD2;EPSTI1;TRIM21;CASP3;IFNAR2;CD69;LY6E;ZNFX1;EIF2AK2;IL15RA;HELZ2;TNFSF10;NFKB1;SERPING1;PSMB10;LCP2;TXNIP;PARP12;IFI44L;IFITM3;NFKBIA;IFI35;SOCS3;CCL2;PSMA3;SAMD9L;CMTR1;PSMA2;IRF2,MSigDB_Hallmark_2020,Interferon Gamma Response,5.0,****,True
